JP7424634B2 - drug feeder - Google Patents

drug feeder Download PDF

Info

Publication number
JP7424634B2
JP7424634B2 JP2020205592A JP2020205592A JP7424634B2 JP 7424634 B2 JP7424634 B2 JP 7424634B2 JP 2020205592 A JP2020205592 A JP 2020205592A JP 2020205592 A JP2020205592 A JP 2020205592A JP 7424634 B2 JP7424634 B2 JP 7424634B2
Authority
JP
Japan
Prior art keywords
drug
rotating body
hanging object
annular rotating
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020205592A
Other languages
Japanese (ja)
Other versions
JP2022092722A (en
Inventor
義人 大村
俊治 大ヶ谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tosho Inc
Original Assignee
Tosho Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosho Inc filed Critical Tosho Inc
Priority to JP2020205592A priority Critical patent/JP7424634B2/en
Priority to CA3205054A priority patent/CA3205054A1/en
Priority to PCT/JP2021/045336 priority patent/WO2022124369A1/en
Priority to EP21903468.3A priority patent/EP4260839A1/en
Priority to AU2021397601A priority patent/AU2021397601A1/en
Priority to US18/256,506 priority patent/US20240016703A1/en
Publication of JP2022092722A publication Critical patent/JP2022092722A/en
Application granted granted Critical
Publication of JP7424634B2 publication Critical patent/JP7424634B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

この発明は、病院や薬局等で行われる調剤を自動化するために、錠剤やアンプル剤といった粒状固形物の薬剤を自動供給するようになった薬剤フィーダに関し、詳しくは、形状の同じ多数の薬剤をランダム収容するとともに、それらの薬剤を回転体で整列させることで、それらの薬剤を一つずつ送り出す逐次送出・順次排出を行う薬剤フィーダに関し、更に詳しくは、薬剤整列時の高さ規制機能の強化に関する。 The present invention relates to a drug feeder that automatically feeds granular solid drugs such as tablets and ampoules in order to automate dispensing in hospitals, pharmacies, etc. Regarding the drug feeder that randomly accommodates drugs and sequentially delivers and sequentially discharges the drugs one by one by arranging them with a rotating body, for more details, we have strengthened the height regulation function when arranging drugs. Regarding.

[背景技術1](特許文献1参照)
同一形状の錠剤等(薬剤)を一列に整列させながら搬送する整列供給式の薬剤フィーダとして、鉛直線を中心として軸回転可能な外側の環状回転体と、鉛直から傾いた傾斜線を中心として軸回転可能な状態で前記環状回転体の内側に装備されて前記環状回転体の中空を塞ぐ傾斜回転体と、前記傾斜回転体の回転によってその上から前記環状回転体の上端周縁部の上に運ばれた固形の薬剤を前記環状回転体の回転時に整列させる規制部材とを備えた薬剤フィーダが実用化されている。
[Background technology 1] (See Patent Document 1)
As an alignment feeding type drug feeder that transports tablets, etc. (drugs) of the same shape while aligning them in a line, it has an outer annular rotating body that can rotate around a vertical line, and a rotating body that rotates around an inclined line that is tilted from the vertical line. a tilted rotor that is rotatably installed inside the annular rotor and closes a hollow space of the annular rotor; A drug feeder has been put into practical use that includes a regulating member that aligns the separated solid drugs when the annular rotating body rotates.

そのうち本願発明の構成や課題などの理解に役立つ部分を、図面を引用して具体的に説明する(図6参照)。
図6は、薬剤フィーダ10のほぼ全容を示しており、(a)が平面図、(b)が縦断正面図である。
Parts that are useful for understanding the structure and problems of the present invention will be specifically explained with reference to the drawings (see FIG. 6).
FIG. 6 shows almost the entire structure of the drug feeder 10, with (a) being a plan view and (b) being a longitudinal sectional front view.

薬剤フィーダ10は、二重回転タイプのものであり、筐体の最上部に位置しており中央部分が円形に刳り抜かれて中空になっている周壁11と、その中空に上端部が遊嵌された状態で設置されている又は周壁11の中空の直下に設置されている環状回転体20と、この環状回転体20の中空内に設置された傾斜回転体30と、この内側の傾斜回転体30とその外側の環状回転体20とを何れも軸回転可能に支持する支承機構40と、それらの回転の駆動を担う回転駆動機構50と、周壁11の上側に設けられた仕分け部材60及び規制機構70とを具えている。 The drug feeder 10 is of a double rotation type, and has a circumferential wall 11 located at the top of the housing and having a circular hollowed out central portion, and an upper end loosely fitted into the hollow circumferential wall 11. An annular rotating body 20 that is installed in a state where it is tilted or installed directly under the hollow of the peripheral wall 11, an inclined rotating body 30 that is installed in the hollow of this annular rotating body 20, and an inclined rotating body 30 inside this A support mechanism 40 that rotatably supports the annular rotating body 20 on the outside thereof, a rotary drive mechanism 50 that is responsible for driving their rotation, and a sorting member 60 and a regulating mechanism provided on the upper side of the peripheral wall 11. 70.

しかも、支承機構40によって、環状回転体20は鉛直線を中心として軸回転しうる状態に保たれ、傾斜回転体30は鉛直から傾いた傾斜線を中心として軸回転しうる状態に保たれる。そして、そのような内側の傾斜回転体30と外側の環状回転体20は、薬剤は通さないが回転は許容される僅かな間隙を保って傾斜回転体30が環状回転体20の中空を塞ぐことで、二重回転タイプ薬剤フィーダの回転容器20+30を構成しており、傾斜回転体30の回転による持ち上げと仕分け部材60の仕分けとによって傾斜回転体30の周縁部33の上から薬剤を環状回転体20の上端周縁部23の上に運び、環状回転体20の回転による水平搬送と規制機構70の整列機能とにて上端周縁部23の上の薬剤を整列させながら落下排出口14へと運ぶようになっている。以下、各部を説明する。 Furthermore, the support mechanism 40 maintains the annular rotating body 20 in a state where it can rotate around a vertical line, and the tilted rotating body 30 in a state where it can rotate around an inclined line that is inclined from the vertical. The inner inclined rotating body 30 and the outer annular rotating body 20 maintain a small gap that does not allow the medicine to pass through but allows rotation, so that the inclined rotating body 30 closes the hollow of the annular rotating body 20. This constitutes the rotating container 20+30 of the double rotation type drug feeder, and the drug is transferred from above the peripheral edge 33 of the inclined rotating body 30 to the annular rotating body by lifting by the rotation of the inclined rotating body 30 and sorting by the sorting member 60. The drugs on the upper end periphery 23 are carried onto the upper end periphery 23 of 20 and transported to the drop discharge port 14 while being aligned by the horizontal transport by the rotation of the annular rotating body 20 and the alignment function of the regulating mechanism 70. It has become. Each part will be explained below.

環状回転体20は、中空の径が上側ほど大きい下部21と、中空の径が上側ほど小さい上部22とからなり、それらの中空に傾斜回転体30を納めてから両部21,22をボルト等で連結することで一体化され、傾斜回転体30と共に回転容器20+30をなす。
傾斜回転体30は、その上面が回転容器20+30の内底になり、図示のものではその上面の央部32の中央に中央突起31が形成されている。また、傾斜回転体30の周縁部33の上面は、一周に亘って、薬剤の掬い上げに役立つ緩い鋸歯状波形に加工されているうえ、掬い上げた薬剤を傾斜による転がりにて円滑に環状回転体20の上端周縁部23へ送り込むことができるよう外下がりの状態になっている。
The annular rotating body 20 consists of a lower part 21 whose hollow diameter is larger toward the upper side, and an upper part 22 whose hollow diameter is smaller toward the upper side.After the inclined rotary body 30 is housed in these hollows, both parts 21 and 22 are connected with bolts, etc. They are integrated by being connected with each other, and together with the tilting rotary body 30, they form a rotary container 20+30.
The top surface of the tilted rotating body 30 serves as the inner bottom of the rotating container 20+30, and in the illustrated example, a central protrusion 31 is formed at the center of a central portion 32 of the top surface. In addition, the upper surface of the peripheral edge 33 of the tilted rotating body 30 is processed into a gentle sawtooth waveform that is useful for scooping up the medicine over one circumference, and the scooped up medicine is smoothly rotated in an annular manner by rolling due to the tilt. It is in a downwardly downward state so that it can be fed into the upper peripheral edge 23 of the body 20.

支承機構40は、各所に分散して配設された複数の部材41~43からなり、それには例えばラジアル軸受などを主体とした受動部材41が幾つかと、例えば硬質ゴム製Oリングなどの輪状体・環状体からなる回転伝動部材42,43とが含まれている。
回転駆動機構50は、回転容器20+30の下に配置された回転駆動部材51と、この回転駆動部材51を軸回転させる回転駆動モータ54とを具備しており、径の異なる回転伝動部材42,43を介する摩擦伝動にて環状回転体20を相対的に高速で軸回転させるとともに、傾斜回転体30を相対的に低速で軸回転させるようになっている。
The support mechanism 40 is composed of a plurality of members 41 to 43 distributed at various locations, including several passive members 41 mainly composed of radial bearings, and an annular body such as a hard rubber O-ring. - Contains rotational transmission members 42 and 43 made of annular bodies.
The rotation drive mechanism 50 includes a rotation drive member 51 disposed below the rotation container 20+30, and a rotation drive motor 54 that rotates the rotation drive member 51. The annular rotating body 20 is rotated around its axis at a relatively high speed by frictional transmission via the rotor, and the tilted rotating body 30 is rotated around its axis at a relatively low speed.

仕分け部材60は、揺動支点の基端部61から揺動端の先端部62まで延びた細長い棒材を主体としたものであり、基端部61が支持部63によって周壁11や環状回転体20の上方で支持されており、そこを中心にして先端部62が上下に揺動しうるようになっている。先端部62寄りの部分が少し曲がっており、常態では先端部62が斜め下向きの状態で自重により軽く傾斜回転体30の周縁部33に乗っているので、その周縁部33から環状回転体20の上端周縁部23へ滑り落ちることなく周縁部33に乗ったまま運ばれて来た薬剤の多くが、先端部62に当接するとともに、その反作用の付勢力によって傾斜回転体30の央部32へ戻されるが、それが円滑に行われなければ薬剤破損等の回避のため先端部62が揺動して上方へ逃げるようにもなっている。 The sorting member 60 is mainly composed of an elongated bar extending from the base end 61 of the swinging fulcrum to the tip end 62 of the swinging end. 20, and the distal end portion 62 can swing up and down about this point. The part near the tip 62 is slightly bent, and in the normal state, the tip 62 is placed diagonally downward and rests lightly on the peripheral edge 33 of the tilted rotating body 30 due to its own weight. Most of the medicine that has been carried along the peripheral edge 33 without sliding down to the upper peripheral edge 23 comes into contact with the tip 62 and is returned to the center 32 of the tilted rotating body 30 by the reaction force. However, if this is not done smoothly, the distal end 62 swings and escapes upward in order to avoid damage to the drug.

規制機構70は、環状回転体20の上端周縁部23の回転方向を基準として仕分け部材60より進行先に設置された第1規制部材71と、それよりも更に進行先に設置された第2規制部材72と、それら第1規制部材71と第2規制部材72との何れにもピン状の回転許容軸部材等を介して連結されているリンク機構73と、サンプル薬剤を収容しうる型置場74とを具備している。
第1規制部材71も、第2規制部材72も、揺動中心部が周壁11側に位置するとともに、揺動端部が環状回転体20の上端周縁部23の上に位置しているので、その上端周縁部23の上の薬剤搬送経路幅を外周側から狭めるものとなっている。
The regulation mechanism 70 includes a first regulation member 71 installed further ahead of the sorting member 60 with respect to the rotational direction of the upper end peripheral edge 23 of the annular rotating body 20, and a second regulation member 71 installed further ahead of the sorting member 60. A member 72, a link mechanism 73 connected to both the first regulating member 71 and the second regulating member 72 via a pin-shaped rotation-permitting shaft member, and a mold storage space 74 that can accommodate a sample drug. It is equipped with.
Both the first regulating member 71 and the second regulating member 72 have their pivoting centers located on the peripheral wall 11 side, and their pivoting ends located above the upper end peripheral portion 23 of the annular rotating body 20. The width of the drug transport path above the upper peripheral edge portion 23 is narrowed from the outer peripheral side.

しかも、第1規制部材71と第2規制部材72は、何れも揺動にて上端周縁部23の上の薬剤搬送経路幅の狭め量を可変調整しうるものであるが、リンク機構73の長手方向進退に応じて両規制部材71,72が同時かつ同様に揺動するので、両規制部材71,72による薬剤搬送経路幅の狭め量の調整量が連動するものともなっている。さらに、型置場74にサンプル薬剤を収容してから、それに向けてリンク機構73を動かすと、リンク機構73が長手方向に進んで先端をサンプル薬剤に当接させて止められるが、そのときに第1規制部材71の揺動端部と第2規制部材72の揺動端部が何れも上端周縁部23の上の薬剤搬送経路幅をサンプル薬剤に倣って薬剤一個相当分に狭めるようにもなっている。 In addition, both the first regulating member 71 and the second regulating member 72 can variably adjust the narrowing amount of the drug transport path width above the upper end peripheral portion 23 by swinging. Since both the regulating members 71 and 72 swing simultaneously and in the same manner in accordance with the direction movement, the amount of adjustment of the narrowing amount of the drug transport path width by the regulating members 71 and 72 is also linked. Furthermore, when the sample drug is stored in the mold storage space 74 and the link mechanism 73 is moved toward it, the link mechanism 73 advances in the longitudinal direction and is stopped by bringing the tip into contact with the sample drug. Both the swinging end portion of the first regulating member 71 and the swinging end portion of the second regulating member 72 narrow the drug transport path width above the upper end peripheral portion 23 by the width of the drug transport path corresponding to the sample drug. ing.

また、そのような規制機構70より更なる進行先では、周壁11に、それを上下に貫通する落下排出口14が形成されており、そこへ環状回転体20の上端周縁部23の上の薬剤を環状回転体20の回転にて送り込むために周壁11には排出ガイド13も設けられている。この排出ガイド13の先端部には、そこより下側に延び且つ先にも延びて最先端となる搬送面ガイド12が形成されていて、薬剤が排出ガイド13に当接した反動で傾斜回転体30の方へ不所望に落下するといったことを防止するようになっている。 In addition, at a further advance point from such a regulating mechanism 70, a fall discharge port 14 is formed in the peripheral wall 11 and passes through it vertically. A discharge guide 13 is also provided on the peripheral wall 11 in order to feed the liquid by the rotation of the annular rotating body 20. A conveyance surface guide 12 is formed at the distal end of the discharge guide 13 and extends downward from there and also extends to the tip, and the reaction of the medicine coming into contact with the discharge guide 13 causes an inclined rotating body This prevents the device from falling undesirably in the direction of 30.

さらに、図示を割愛したが、回転駆動モータ54の動作制御を担うコントローラと、それらに動作電力を供給する電源も、同じ筐体に内蔵して又は筐体の外に設けられている。また、落下排出口14における薬剤の落下を検出するフォトセンサ等も付設されており、その検出信号がコントローラや錠剤カウンタへ送信される。
コントローラの回転制御は、低速回転から始まり、最初の薬剤の排出を検出した後、更に、予め設定された所定数の薬剤の排出を検出すると、高速回転に移行するようになっている。また、予め指定された総排出数と排出済み個数とから残数を算出するとともに、やはり指定された所定数に残数が達すると回転速度を落としたり、薬剤排出完了後に不所望な過剰落下の防止のため逆回転を行わせるようにもなっている。
Furthermore, although not shown, a controller that controls the operation of the rotary drive motor 54 and a power source that supplies operating power to the controller are also built into the same housing or provided outside the housing. Further, a photo sensor and the like for detecting the falling medicine at the drop outlet 14 is also attached, and the detection signal is sent to the controller and the tablet counter.
The rotation control of the controller starts from low-speed rotation, and after detecting the discharge of the first drug and further detects the discharge of a predetermined number of drugs, shifts to high-speed rotation. In addition, the remaining number is calculated from the total number of discharged medicines specified in advance and the number of discharged medicines, and when the remaining number reaches a predetermined number that has also been specified, the rotation speed is reduced, and after the completion of medicine discharge, it is possible to prevent undesired excessive drops. To prevent this, it is also designed to rotate in the opposite direction.

このような薬剤フィーダ10の動作等についても説明する。薬剤フィーダ10を使用して多数の薬剤を逐次送出するには、それに先だって、薬剤搬送経路幅の規制作業と薬剤のランダム投入とを済ませておく。
そのうち、薬剤搬送経路幅の規制作業は、作業担当者が、多数の薬剤のうちから適宜な一個を型用薬剤に選出して、それを型置場74に収めてから、それにリンク機構73の一端が当接するようにリンク機構73の位置を調整するという簡単なことで、遂行される。
The operation of such medicine feeder 10 will also be explained. Before sequentially delivering a large number of drugs using the drug feeder 10, the work of regulating the width of the drug transport path and the random injection of drugs are completed.
In the work of regulating the width of the drug transport path, the worker selects an appropriate one from among a large number of drugs as a molding agent, stores it in the mold storage space 74, and then attaches it to one end of the link mechanism 73. This can be accomplished simply by adjusting the position of the link mechanism 73 so that the two abut against each other.

その作業が行われると、第1規制部材71と第2規制部材72とが何れもリンク機構73に連動して揺動し、それらの揺動端部によって環状回転体20の上端周縁部23の上の薬剤搬送経路幅が二カ所で型用薬剤の直径に対応するところまで狭められる。
また、薬剤のランダム投入は、やはり作業担当者が、文字通り多数の薬剤を環状回転体20の上部開口から回転容器20+30へランダムに投入すれば良い。
そうすると、投入されたランダム収容薬剤は、自然に、傾斜回転体30の上面のうち下側に来ている部分の上に集まる。
When this work is performed, both the first regulating member 71 and the second regulating member 72 swing in conjunction with the link mechanism 73, and their swinging ends cause the upper end peripheral portion 23 of the annular rotating body 20 to The width of the upper drug delivery path is narrowed at two locations to correspond to the diameter of the molding drug.
In addition, for random injection of drugs, the operator may literally inject a large number of drugs into the rotating containers 20+30 from the upper opening of the annular rotating body 20 at random.
Then, the randomly stored medicines that have been thrown in will naturally gather on the lower part of the upper surface of the tilting rotating body 30.

これで自動動作の準備が調うので、薬剤フィーダ10を例えば単純な連続送出モード等で動作させると、以後はコントローラの制御に従って回転駆動モータ54が適宜な速度で回転する。そうすると、それに応じて回転駆動部材51が軸回転し、その回転運動が、大径部外装回転伝動部材42を介した摩擦伝動にて環状回転体20に伝達されるとともに、小径部外装回転伝動部材43を介した摩擦伝動にて傾斜回転体30にも伝達されて、大径部外装回転伝動部材42と小径部外装回転伝動部材43とが同じ向きに軸回転するが、大径部外装回転伝動部材42の方が小径部外装回転伝動部材43より高速で回転する。 The automatic operation is now ready, so when the drug feeder 10 is operated in, for example, a simple continuous delivery mode, the rotary drive motor 54 rotates at an appropriate speed under the control of the controller. Then, the rotary drive member 51 rotates around its axis in response to this, and the rotational motion is transmitted to the annular rotating body 20 by friction transmission via the large-diameter exterior rotation transmission member 42, and the small-diameter exterior rotation transmission member 43 is also transmitted to the inclined rotating body 30 by friction transmission, and the large-diameter exterior rotation transmission member 42 and the small-diameter exterior rotation transmission member 43 rotate in the same direction. The member 42 rotates at a higher speed than the small diameter exterior rotation transmission member 43.

傾斜回転体30が軸回転すると、回転容器20+30の内底に溜まっていたランダム収容薬剤のうち傾斜回転体30の周縁部33の上に来ていた薬剤が、鋸歯状の周縁部33の循環運動によって低位置から高位置へ掬い上げられる。
そうして、周縁部33が環状回転体20の上端周縁部23よりも高くなるところまで運ばれた薬剤は、大部分が周縁部33の傾斜に基づく滑落や転動によって上端周縁部23の上へ乗り移る。
When the tilted rotary body 30 rotates, the medicine that has been on the peripheral edge 33 of the tilted rotary body 30 among the randomly stored medicines accumulated on the inner bottom of the rotating container 20+30 is moved by the circular movement of the sawtoothed peripheral edge 33. scooped up from a low position to a high position.
Most of the medicine carried to the point where the peripheral edge 33 is higher than the upper peripheral edge 23 of the annular rotating body 20 rises above the upper peripheral edge 23 by sliding or rolling due to the slope of the peripheral edge 33. Transfer to.

これに対し、上端周縁部23の上が先行の他の薬剤で詰まっていたり、たまたま滑落や転動しなかったといった理由で、傾斜回転体30の周縁部33の上に残っていた薬剤は、傾斜回転体30の更なる軸回転によって仕分け部材60の先端部62の所へ運ばれ、そこで先端部62に当接し、その当接の反動によって上端周縁部23とは逆の向きに移動させられるため、傾斜回転体30の央部32を傾斜面に沿って滑落する。
こうして、過剰な薬剤がランダム収容薬剤に戻るので、上端周縁部23の上の薬剤搬送経路には或る程度絞り込まれて適量に近い頻度で薬剤が送り込まれる。
On the other hand, the medicine remaining on the peripheral edge 33 of the tilted rotary body 30 because the upper end peripheral edge 23 was clogged with other preceding medicines, or because it happened to not slide down or roll. Further axial rotation of the tilting rotary body 30 carries it to the tip 62 of the sorting member 60, where it abuts the tip 62, and is moved in the opposite direction to the upper peripheral edge 23 by the reaction of the abutment. Therefore, the central portion 32 of the tilted rotating body 30 slides down along the tilted surface.
In this way, the excess drug returns to the randomly stored drug, so that the drug delivery path above the upper peripheral edge 23 is narrowed down to some extent and the drug is sent at a frequency close to the appropriate amount.

環状回転体20の方が傾斜回転体30より高速で軸回転しているので、上端周縁部23の上の薬剤は、周縁部33から乗り移ったときに回転速度の差に応じて或る程度はばらけるが、薬剤が小さめの場合など、縦一列になるものもあれば、真横や斜め横に並ぶものもありうる。そして、それらの薬剤が、環状回転体20の軸回転によって第1規制部材71の所へ運ばれると、一列の薬剤はそのまま通過するが、横並びの薬剤については第1規制部材71との干渉によって内側の薬剤が上端周縁部23の上から押し出されて傾斜回転体30の上に落下しランダム収容薬剤に戻るので、横並びが解消される。 Since the annular rotating body 20 is axially rotating at a higher speed than the inclined rotating body 30, the drug on the upper peripheral edge 23 will be rotated to some extent depending on the difference in rotational speed when transferred from the peripheral edge 33. They may come apart, but if the medicine is small, some may be arranged in a vertical line, while others may be lined up horizontally or diagonally. When these drugs are carried to the first regulating member 71 by the rotation of the axis of the annular rotating body 20, the drugs in one row pass through as they are, but the drugs in the horizontal row are caused by interference with the first regulating member 71. The medicine inside is pushed out from above the upper peripheral edge part 23 and falls onto the tilted rotating body 30, returning to the randomly stored medicine, so that the side-by-side arrangement is eliminated.

とはいえ、横並びの薬剤が多いとき等には、薬剤同士の押し合い等によって第1規制部材71の先端を巻くようにすり抜ける薬剤もありうる。そして、そのような場合、第1規制部材71を通過した薬剤のうち一部のものには斜め横の並び状態が残ったりすることがある。いずれにしろ、第1規制部材71を通過した薬剤は、その後、環状回転体20の軸回転よって第2規制部材72の所へ運ばれて、再び同様の整列が強制されるため、例え横並び状態が残っていても僅かなものにすぎないうえ程度も斜め横の並びの軽い状態にとどまることから、横並び状態が再度の規制で迅速かつ十分に解消される。 However, when there are many drugs arranged side by side, some drugs may slip around the tip of the first regulating member 71 due to pushing each other. In such a case, some of the drugs that have passed through the first regulating member 71 may remain in a diagonally horizontal arrangement. In any case, the drugs that have passed through the first regulating member 71 are then carried to the second regulating member 72 by the axial rotation of the annular rotating body 20 and are again forced to be aligned in the same way. Even if there remains, it is only a small amount and the degree remains only in a diagonal horizontal arrangement, so the horizontal arrangement can be quickly and sufficiently resolved by reintroducing the regulation.

このようにして二重の規制をクリアして一列に整列した整列済み薬剤は、環状回転体20の軸回転に伴う上端周縁部23の循環運動によって次々に排出ガイド13の所へ運ばれ、上端周縁部23の上の薬剤搬送経路と斜めに交差している排出ガイド13の外側側面に当接する。
そして、整列済み薬剤の多くは、直ちに排出ガイド13の当接側面に沿って進み、一列になって落下排出口14に送り込まれる。
In this way, the aligned drugs cleared the double regulation and aligned in a line are carried one after another to the discharge guide 13 by the circulation movement of the upper end peripheral portion 23 accompanying the rotation of the axis of the annular rotating body 20, and It comes into contact with the outer side surface of the discharge guide 13 that obliquely intersects with the drug transport path on the peripheral edge 23 .
Most of the aligned drugs immediately proceed along the abutting side surface of the discharge guide 13 and are fed into the falling discharge port 14 in a line.

もっとも、当接状況によっては希に一部の整列済み薬剤が内周側へ少しはじかれることもあるが、そのような状況が生じたときでも、整列済み薬剤の環状回転体20の上への落下や、上端周縁部23と排出ガイド13との斜交部位への挟み込みは、搬送面ガイド12によって阻止される。
こうして、総ての整列済み薬剤が無駄なく一列で落下排出口14に送り込まれる。落下排出口14に送り込まれた薬剤は重力で加速されて落下速度を増すことから、先後の薬剤の離隔距離が広がるので、その離隔距離が十分になる所に設置したフォトセンサ等で落下薬剤を検出するといったことで、的確に、薬剤を計数することができる。
However, depending on the contact situation, some of the aligned drugs may be slightly repelled toward the inner periphery, but even when such a situation occurs, the aligned drugs will not be pushed onto the annular rotating body 20. The transport surface guide 12 prevents the transport surface guide 12 from falling or being caught in the diagonally intersecting region between the upper end peripheral portion 23 and the discharge guide 13 .
In this way, all the arranged medicines are fed into the drop discharge port 14 in a single line without waste. Since the medicine sent into the falling discharge port 14 is accelerated by gravity and increases its falling speed, the separation distance between the preceding and following medicines increases, so a photo sensor or the like installed at a place where the separation distance is sufficient is used to detect the falling medicine. By detecting the drug, it is possible to accurately count the number of drugs.

このような薬剤フィーダにあっては、二重回転タイプ薬剤フィーダを基本にしたことにより、すなわち、回転容器を内外二重化してそれらの回転にて内側の傾斜回転体から外側の環状回転体の上端周縁部の上に固形薬剤を運び更にその固形薬剤を規制部材にて整列させるようにしたことにより、回転体の中に固定の整流ガイドを設ける必要が無くなったばかりか、種々の形状やサイズの薬剤に対する共用範囲が広がっている。 This type of drug feeder is based on a double-rotation type drug feeder, that is, the rotating container is made into an inner and outer double container, and the upper end of the outer annular rotating body is moved from the inner tilted rotating body to the upper end of the outer annular rotating body by rotation of the inner and outer rotating containers. By conveying the solid medicine above the peripheral edge and aligning the solid medicine with the regulating member, not only is there no need to provide a fixed rectification guide in the rotating body, but also medicines of various shapes and sizes can be aligned. The scope of sharing is expanding.

また、このような薬剤フィーダにあっては、環状回転体の上端周縁部の上で固形薬剤を安定姿勢で一列に整列させるために、薬剤の横幅を規制する規制機構が前後に連ねて二つ装備されるとともに、薬剤の高さを規制する仕分け部材が上記の規制機構に前置されており、それらによって整列機能が適切に発揮されているが、それらの部材のうち仕分け部材は、既述したように薬剤破損等の回避のため薬剤からの反力が強いときには先端部が揺動して上方へ逃げるようになっているため、高さ規制が常に確実に行われると言い切れる訳ではないが、仕分け部材による高さ規制は、規制機構による幅規制の負担を軽減するための前処理といったものなので、実用上の不都合が有る訳ではない。 In addition, in such a drug feeder, in order to align the solid drugs in a stable position in a line on the upper edge of the annular rotating body, two regulating mechanisms for regulating the width of the drugs are arranged in front and back. At the same time, a sorting member for regulating the height of the medicine is placed in front of the above-mentioned regulating mechanism, and the alignment function is properly exerted by these members. As mentioned above, in order to avoid chemical damage, the tip swings and escapes upward when the reaction force from the chemical is strong, so it cannot be said that height regulation will always be carried out reliably. However, since the height regulation by the sorting member is a pre-processing to reduce the burden of width regulation by the regulation mechanism, there is no practical disadvantage.

[背景技術2](特許文献2,3参照)
これに対し、上述のように共用範囲が広がると、形状やサイズの相違だけでなく、材質の異なる薬剤たとえば硬めの薬剤だけでなく表層の脆い薬剤や、球状や紡錘状といった転がり易い形状の薬剤などについても共用の要望が高まる。
そして、それに応じて脆い薬剤や転がり易い薬剤も取り扱うには、薬剤の損傷や過剰な転動を回避・抑制するために、薬剤と仕分け部材との当たりが和らぐようにするといった謂わば仕分け部材の繊細化や多様化が求められる。
[Background technology 2] (See Patent Documents 2 and 3)
On the other hand, when the scope of common usage expands as mentioned above, there are not only differences in shape and size, but also drugs of different materials, such as drugs with brittle surfaces as well as hard drugs, and drugs with easy-to-roll shapes such as spherical and spindle shapes. There will also be an increasing demand for sharing such things.
In order to handle fragile drugs or drugs that roll easily, the so-called sorting member must be adjusted so that the contact between the drug and the sorting member is softened in order to avoid or suppress damage to the drug or excessive rolling. Subtlety and diversification are required.

しかしながら、そのような対処は仕分け部材の高さ規制機能を弱めがちなので、単純な繊細化等にとどまることなく、薬剤と仕分け部材との当たりを緩和しても高さ規制機能が維持されるような更には強化されるような対策をも加味した対処方が望まれる。
そこで、二重回転タイプ薬剤フィーダを踏襲しつつ更に薬剤整列時の高さ規制機能を維持しつつも薬剤に対する仕分け部材の当たりは緩やかな薬剤フィーダを実現することが更なる技術的課題となった。
However, such measures tend to weaken the height regulation function of the sorting member, so rather than simply making it more delicate, efforts should be made to maintain the height regulation function even if the contact between the drug and the sorting member is relaxed. What's more, it is desirable to take measures that can be strengthened.
Therefore, an additional technical challenge was to create a drug feeder that follows the dual rotation type drug feeder and maintains the height regulation function when arranging drugs, while the sorting member makes gentle contact with the drugs. .

そして、そのような技術課題を解決するために、縦線を中心として軸回転可能な外側の環状回転体と、前記縦線から傾いた傾斜線を中心として軸回転可能な状態で前記環状回転体の内側に装備されて前記環状回転体の中空を塞ぐ傾斜回転体と、前記傾斜回転体の回転によってその上から前記環状回転体の上端周縁部の上に運ばれた固形の薬剤を前記環状回転体の回転時に整列させる仕分け部材および規制部材とを備えた薬剤フィーダであって、前記規制部材が前記環状回転体の前記上端周縁部の上の薬剤に対して横幅を規制するようになっており、前記仕分け部材が、前記環状回転体の前記上端周縁部の上方に垂れ下がっていて下端部を横に押されると変形しうる垂下物を具備していることにより前記環状回転体の前記上端周縁部の上の薬剤に対して高さを規制するようになっており、前記垂下物が複数の球体を緩く連結したものからなる、という薬剤フィーダが開発された。 In order to solve such technical problems, the outer annular rotating body is rotatable about a vertical line, and the annular rotating body is rotatable about an inclined line tilted from the vertical line. a tilted rotary body installed inside the annular rotary body to close the hollow space of the annular rotary body; A drug feeder comprising a sorting member and a regulating member that are aligned when the body rotates, the regulating member regulating the width of the drug on the upper peripheral edge of the annular rotating body. , the sorting member includes a hanging object that hangs above the upper peripheral edge of the annular rotating body and can be deformed when the lower end is pushed sideways, whereby the upper peripheral edge of the annular rotating body A drug feeder has been developed in which the height of the drug above the drug feeder is regulated, and the hanging object consists of a plurality of loosely connected spheres.

そのうち本願発明の課題等の理解に役立つ部分を、既述の薬剤フィーダ10を改良した薬剤フィーダ100に係る図面を引用して具体的に説明する(図7~図9参照)。
図7は、薬剤フィーダ100の全体構成を示す縦断面図である。
Parts that are useful for understanding the problems of the present invention will be specifically explained with reference to the drawings of a drug feeder 100 that is an improved version of the drug feeder 10 described above (see FIGS. 7 to 9).
FIG. 7 is a longitudinal sectional view showing the overall configuration of the drug feeder 100.

図8は、既述の規制機構70を改良した規制機構700の構成を示し、(a)が、型用薬剤5aを型置場74に置いたときの規制機構700に係る平面図、(b)が、第1規制部材710の平面図と端面図である。
図9は、既述の仕分け機構60を改良した仕分け機構600の構成を示しており、(a)が、仕分け機構600とその設置先部分とに係る外観斜視図であり、(b)が、仕分け機構600の第1仕分け部材610に係る正面図であり、(c)が、仕分け機構600の第2仕分け部材620に係る正面図である。
FIG. 8 shows the configuration of a regulating mechanism 700 that is an improved version of the previously described regulating mechanism 70, in which (a) is a plan view of the regulating mechanism 700 when the molding agent 5a is placed in the molding place 74, and (b) is a plan view of the regulating mechanism 700. are a plan view and an end view of the first regulating member 710.
FIG. 9 shows the configuration of a sorting mechanism 600 that is an improved version of the sorting mechanism 60 described above, in which (a) is an external perspective view of the sorting mechanism 600 and its installation location, and (b) is FIG. 6C is a front view of the first sorting member 610 of the sorting mechanism 600, and FIG.

薬剤フィーダ100が既述の薬剤フィーダ10と相違する点としては(図7参照)、回転駆動機構50が二つの回転駆動モータ54a,54bを具備して環状回転体20の回転と傾斜回転体30の回転とを個別に制御できるようになったことや、環状回転体20がそれを上下に分解しなくても傾斜回転体30を抜き差しできる椀状の一体物になったこと、傾斜回転体30の着脱を検出する傾斜回転体装着検出手段55が追加されたこと、落下排出口14の下方の薬剤落下検出手段56が明示されたこと等が挙げられる。 The difference between the drug feeder 100 and the previously described drug feeder 10 (see FIG. 7) is that the rotational drive mechanism 50 includes two rotational drive motors 54a and 54b to rotate the annular rotating body 20 and the tilted rotating body 30. The rotation of the annular rotating body 20 can now be controlled individually, and the annular rotating body 20 has become a bowl-shaped unit that allows the tilting rotating body 30 to be inserted and removed without disassembling it vertically. Examples include the addition of a tilting rotating body attachment detecting means 55 for detecting the attachment and detachment of the drug, and the clear identification of a drug drop detecting means 56 below the drop discharge port 14.

さらに、規制機構70が改造されて規制機構700になったことと、仕分け部材60が改造されて仕分け機構600になったことが、挙げられる
ここでは、それらの相違点のうち、本願発明の課題と密に関係する規制機構700と仕分け機構600とについて、詳述する。
Furthermore, the regulation mechanism 70 has been modified to become the regulation mechanism 700, and the sorting member 60 has been modified to become the sorting mechanism 600. The regulating mechanism 700 and sorting mechanism 600, which are closely related to each other, will be described in detail.

規制機構700は(図8(a)参照)、既述した規制機構70を引き継ぐに際して、型用薬剤5aをセットする型置場74や、規制部材71,72を連動させるリンク機構73は、概ねそのまま引き継いでいるが、第1規制部材71と第2規制部材72には改良が施されて、それぞれ第1規制部材710と第2規制部材720になっている。
第1,第2規制部材710,720は同形なので、一方710を詳述するが(図8(b)参照)、第1規制部材710は、既述の第1規制部材71と同様、図では左端の揺動中心部が周壁11側に位置し、図では右端の揺動端部が環状回転体20の上端周縁部23の上方に位置し、リンク機構73の長手方向進退に応じて上端周縁部23の上の薬剤搬送経路幅を外周側から狭める横幅規制機能を発揮するものとなっている。
When the regulating mechanism 700 (see FIG. 8(a)) takes over the previously described regulating mechanism 70, the mold storage area 74 in which the mold chemical 5a is set and the link mechanism 73 that interlocks the regulating members 71 and 72 are generally kept as they are. However, the first regulating member 71 and the second regulating member 72 have been improved to become the first regulating member 710 and the second regulating member 720, respectively.
Since the first and second regulating members 710 and 720 have the same shape, only one 710 will be described in detail (see FIG. 8(b)). The left end swinging center is located on the peripheral wall 11 side, and in the figure, the right end swinging end is located above the upper end peripheral edge 23 of the annular rotating body 20, and the upper end peripheral edge moves forward and backward in the longitudinal direction of the link mechanism 73. It exhibits a width regulating function of narrowing the width of the drug transport path above the portion 23 from the outer circumferential side.

しかも、第1規制部材710は(図8(b)参照)、内周側面部が改造されており、内周側面部に、既述の第1規制部材71の内周側面部を踏襲していて横幅規制機能を担う下段部分711だけでなく、既述の第1規制部材71には無かった上段部分712も、形成されている。上段部分712は、下段部分711よりも内周側に張り出しており、上段部分712と下段部分711との間は傾斜面になっている。そのため、第1規制部材710は、下段部分711がリンク機構73の状態に応じた厳密な横幅規制機能を行うのに加えて、上段部分712が緩やかな高さ規制を行うものとなる。
繰り返しとなる詳細な説明は割愛するが、第2規制部材720も同様である。
Moreover, the first regulating member 710 (see FIG. 8(b)) has a modified inner circumferential side surface, and the inner circumferential side surface follows the inner circumferential side surface of the first regulating member 71 described above. In addition to the lower part 711 that plays a width regulating function, an upper part 712, which was not present in the first regulating member 71 described above, is also formed. The upper portion 712 projects further inward than the lower portion 711, and there is an inclined surface between the upper portion 712 and the lower portion 711. Therefore, in the first regulating member 710, the lower part 711 performs a strict width regulation function according to the state of the link mechanism 73, and the upper part 712 performs gentle height regulation.
The same applies to the second regulating member 720, although a detailed explanation will be omitted.

図9に示した仕分け機構600は、既述の仕分け部材60を改造したものであり、本願発明の適用対象の中心的な部位である。
図9は、薬剤フィーダ100の仕分け機構600の構造を示しており、(a)が仕分け機構600とその設置先部分とに係る外観斜視図であり、(b)が仕分け機構600の第1仕分け部材610に係る正面図であり、(c)が仕分け機構600の第2仕分け部材620に係る正面図である。
The sorting mechanism 600 shown in FIG. 9 is a modified version of the previously described sorting member 60, and is a central part to which the present invention is applied.
9 shows the structure of the sorting mechanism 600 of the drug feeder 100, in which (a) is an external perspective view of the sorting mechanism 600 and its installation location, and (b) is a first sorting mechanism of the sorting mechanism 600. 6 is a front view of the member 610, and FIG. 6C is a front view of the second sorting member 620 of the sorting mechanism 600. FIG.

仕分け機構600は(図9(a)参照)、環状回転体200の上端周縁部230の薬剤搬送経路において既述の仕分け部材60と同様に規制機構700の上流に配設された第1仕分け部材610と、仕分け部材60と異なり上記の薬剤搬送経路において規制機構700と並ぶ位置に配設された第2仕分け部材620とを具備しており、それら複数の部材にて多段階で仕分け機能を発揮するものになっている。
何れの部材610,620も、既述の仕分け部材60と同様に、排出ガイド13を含むとともに規制機構700を支持する板体に対して、装着されている。
The sorting mechanism 600 (see FIG. 9(a)) is a first sorting member disposed upstream of the regulating mechanism 700 in the drug transport path of the upper end peripheral portion 230 of the annular rotating body 200, similar to the sorting member 60 described above. 610, and a second sorting member 620, which is disposed in a position parallel to the regulating mechanism 700 in the drug transport path, unlike the sorting member 60, and these plural members perform a sorting function in multiple stages. It has become something to do.
Both members 610 and 620 are attached to a plate body that includes the discharge guide 13 and supports the regulation mechanism 700, similarly to the sorting member 60 described above.

第1仕分け部材610は(図9(a),(b)参照)、手動のネジ機構にて上下位置を調整しうる短かめの支持部材611と、その先端寄り部位に取り付けられて支持部材611に随伴して上下する前段垂下物612(第1形の垂下物)とを具備している。
前段垂下物612は(図9(b)参照)、複数の大玉613(図では二個の球体)を緩く連結して鎖状にしたものであり、市販のボールチェーン等で足りれば容易かつ安価に具現化できる。第1仕分け部材610では、二個の前段垂下物612が、支持部材611から上端周縁部230の薬剤搬送経路の上方へ横並び状態で垂れ下がり、通常は前段垂下物612の下端が薬剤の高さより少しだけ高くなるように上下位置が調整される。
The first sorting member 610 (see FIGS. 9A and 9B) includes a short support member 611 whose vertical position can be adjusted using a manual screw mechanism, and a short support member 611 that is attached to a portion near the tip of the support member 611. It is provided with a front-stage hanging object 612 (first type hanging object) that moves up and down accordingly.
The front hanging object 612 (see FIG. 9(b)) is made up of a plurality of large balls 613 (two spheres in the figure) loosely connected to form a chain, and can be easily and easily constructed using a commercially available ball chain or the like. It can be realized at low cost. In the first sorting member 610, two front-stage hanging objects 612 hang side by side from the support member 611 above the drug transport path of the upper end peripheral portion 230, and normally the lower ends of the front-stage hanging objects 612 are slightly lower than the height of the medicine. The vertical position is adjusted so that the

第2仕分け部材620は(図9(a),(c)参照)、これも手動で上下位置を調整しうる長めの支持部材621と、その先端寄り部位に取り付けられて支持部材621に随伴して上下する中段垂下物622及び後段垂下物632(何れも第1形の垂下物)と、支持部材621の上下位置調整を担う手動調整機構650とを具備している。
中段垂下物622は(図9(c)参照)、複数の中玉623(図では三個の球体)を緩く連結して鎖状にしたものであるが、中玉623が小粒になり連結個数が増えている。
後段垂下物632も、やはり複数(図では手前七個と奥六個)の小玉633を緩く連結して鎖状にしたものであり、小玉633が更に小粒になり連結個数が増えている。
The second sorting member 620 (see FIGS. 9(a) and 9(c)) includes a longer support member 621 whose vertical position can also be manually adjusted, and a longer support member 621 that is attached to a portion near the tip of the support member 621 to accompany the support member 621. The support member 621 includes a middle hanging object 622 and a rear hanging object 632 (both of which are first type hanging objects) that move up and down, and a manual adjustment mechanism 650 that adjusts the vertical position of the support member 621.
The middle hanging object 622 (see FIG. 9(c)) is made up of a plurality of medium beads 623 (three spheres in the figure) loosely connected to form a chain, but the medium beads 623 are small and the number of connected objects is reduced. is increasing.
The rear hanging object 632 is also formed by loosely connecting a plurality of small beads 633 (seven in the front and six in the back in the figure) to form a chain, and the beads 633 are even smaller and the number of connected beads is increasing.

手動調整機構650は、支持部材621を手動操作にて上げてそれと下限設定機構651との間隙を広げてから、下限設定機構651の上に型用薬剤5b(上述した型置場74に置いた図8(a)の型用薬剤5aとは別物であるが同形の薬剤の一つ)を載置し、それから手動操作にて支持部材621を型用薬剤5bに軽く当たるところまで下げると、支持部材621の上下位置が型用薬剤5bに対応した位置に来るようになっている。
下限設定機構651には、目盛部材652が付設されており(図9(c)参照)、その目盛が下限設定機構651と支持部材621との間隔ひいては型用薬剤5bのサイズを示し更には手動調整機構650によって調整された第2仕分け部材620による規制高さをも示すようになっている。また、支持部材621の上下位置調整に付随して、型用薬剤5aの採寸・表示まで行われるので、第1仕分け部材610の調整の目安にもなる。
The manual adjustment mechanism 650 manually raises the support member 621 to widen the gap between it and the lower limit setting mechanism 651, and then places the molding agent 5b on the lower limit setting mechanism 651 (as shown in the figure placed in the mold storage space 74 described above). 8(a) is placed, and then manually lowered the support member 621 to a point where it lightly touches the molding agent 5b. The vertical position of 621 is arranged to correspond to the molding agent 5b.
A scale member 652 is attached to the lower limit setting mechanism 651 (see FIG. 9(c)), and the scale indicates the distance between the lower limit setting mechanism 651 and the support member 621 and the size of the molding agent 5b. The height regulated by the second sorting member 620 adjusted by the adjustment mechanism 650 is also shown. Further, since the measurement and display of the molding agent 5a are performed in conjunction with the vertical position adjustment of the support member 621, it also serves as a guide for adjusting the first sorting member 610.

さらに、上述した前段垂下物612と中段垂下物622と後段垂下物632とについて、それらの位置関係や役割分担等を説明する。
二つの前段垂下物612は、何れも上端周縁部230の薬剤搬送経路の上方に垂れ下がるが、上端周縁部230の径方向である薬剤搬送経路の横断方向に並んでいる。前段垂下物612の下端位置は、調整方針に依存するので一概には言えないが、大抵は、薬剤搬送経路上で薬剤が重なっていれば上の薬剤に対して干渉するように、薬剤より少し高くされる。大玉613が重めで薬剤の重なりが効率良く解消されるが、自由端である下端の大玉613が直ぐ上の連結部の変形によって逃げるため薬剤への衝撃は少なくて済む。
Furthermore, the positional relationship, role sharing, etc. of the above-described front hanging object 612, middle hanging object 622, and rear hanging object 632 will be explained.
The two front hanging objects 612 both hang down above the drug transport path of the upper peripheral edge 230, but are lined up in the radial direction of the upper peripheral edge 230, which is the transverse direction of the drug transport path. The lower end position of the front hanging object 612 cannot be generalized because it depends on the adjustment policy, but in most cases, it is placed slightly lower than the drug so that if the drugs overlap on the drug delivery path, it will interfere with the drug above. be made expensive. Since the large balls 613 are heavy, the overlapping of the medicines is efficiently resolved, but since the large balls 613 at the lower end, which is the free end, escapes by deformation of the connecting portion directly above, there is less impact on the medicines.

なお、薬剤が球状の場合は、薬剤が転がり易くて位置が安定しないことが多いが、薬剤が薬剤搬送経路の横断方向で中央など望ましい所に位置しているときには、薬剤が横並びの前段垂下物612の間をすり抜ける。また、薬剤が中央より少し横にずれているときには、位置ずれしている方の前段垂下物612と薬剤とが軽く干渉して、薬剤が中央(転がり易い薬剤では上述した環状回転体200の上端周縁部230の溝231の拡幅部のところ)に寄せられる。これに対し、薬剤が中央から大きく位置ずれしているときには、当たり具合によって中央に寄せられる薬剤もあるが上端周縁部230の上から押し出されて傾斜回転体300の上に戻る薬剤が多い。 In addition, when the drug is spherical, it tends to roll and its position is often unstable, but when the drug is located at a desirable location such as the center in the transverse direction of the drug delivery route, the drug is placed in a horizontally arranged front hanging object. Pass through between 612. In addition, when the drug is slightly shifted laterally from the center, the drug slightly interferes with the front hanging object 612 that is shifted from the center, and the drug is moved to the center (for drugs that easily roll, the upper end of the annular rotating body 200 described above). (at the widened portion of the groove 231 of the peripheral portion 230). On the other hand, when the drug is largely deviated from the center, some of the drug is moved to the center depending on how it hits, but most of the drug is pushed out from above the upper end peripheral portion 230 and returns to the top of the tilted rotating body 300.

二つの中段垂下物622は、その支持部材621が規制機構700を跨いでいる跨ぎ仕分け部材になっていて、何れの中段垂下物622も、上端周縁部230の薬剤搬送経路の上方に垂れ下がり、規制機構700(特に第2規制部材720)の横に位置していて横並び垂下物になっている。
また、何れの中段垂下物622も、上端周縁部230の薬剤搬送経路の上方に位置しており、それらが薬剤搬送経路に対しては斜めに並んでいる。
The support members 621 of the two middle-stage hanging objects 622 are straddling sorting members that straddle the regulation mechanism 700, and both middle-stage hanging objects 622 hang above the drug transport path of the upper end peripheral portion 230, and the regulating mechanism 700 is straddled. It is located next to the mechanism 700 (particularly the second regulating member 720) and is a horizontally hanging object.
Further, both of the middle-stage hanging objects 622 are located above the drug transport path of the upper end peripheral portion 230, and are lined up diagonally with respect to the drug transport path.

さらに、支持部材621と手動調整機構650との関係が標準的な設定では中段垂下物622の下端位置を薬剤搬送経路上の薬剤より僅かに低くするようになっている。
そのため、中段垂下物622は、薬剤搬送経路上で薬剤が重なっていれば上の薬剤に対して中玉623が干渉して薬剤の重なりを解消する機能に加え、例えば単独で孤立した状態や斜めがかった横並び状態などでたまたま薬剤搬送経路の内周側に載っているような薬剤を剤搬送経路の中央へ戻すか傾斜回転体300へ戻すか切り分けることで薬剤搬送経路上の薬剤整列機能を強化する機能をも発揮するものとなっている。
Further, in a standard setting of the relationship between the support member 621 and the manual adjustment mechanism 650, the lower end position of the middle hanging object 622 is set slightly lower than the drug on the drug transport path.
Therefore, the middle hanging object 622 has the function of eliminating the overlapping of drugs by interfering with the drug on the upper drug if drugs overlap on the drug transport path, as well as eliminating the overlapping of the drugs, for example, when the middle hanging object 622 The drug alignment function on the drug delivery path is strengthened by determining whether drugs that happen to be placed on the inner circumference side of the drug delivery path in a side-by-side state are returned to the center of the drug delivery path or to the tilted rotating body 300. It also has the function of

二つの後段垂下物632は(図9(a)参照)、一方(図では奥の六連物)が上端周縁部230の薬剤搬送経路の内周側の上方に垂れ下がり、他方が(図では手前の七連物)が上端周縁部230の薬剤搬送経路の上方から外れて傾斜回転体300の外周側の上方に垂れ下がり、薬剤搬送経路の横断方向に並んでいる。
しかも、手動調整機構650による支持部材621の高さ調整に伴って、一方の後段垂下物632の下端位置は上述の中段垂下物622の下端位置より少し低くされ、他方の後段垂下物632の下端位置は更に低くされるようになっている。
そのため、上述した大玉613を連ねた第1仕分け部材610と、中玉623を連ねた中段垂下物622と、小玉633を連ねた後段垂下物632は、それらの下端位置が玉の大小の順になっている。
Of the two rear hanging objects 632 (see FIG. 9(a)), one (the six-part object at the back in the figure) hangs above the inner circumferential side of the drug delivery path of the upper end peripheral portion 230, and the other (the one at the front in the figure) The seven-piece series) is removed from above the drug transport path of the upper end peripheral edge portion 230 and hangs down above the outer peripheral side of the tilted rotating body 300, and is lined up in the transverse direction of the drug transport path.
Moreover, as the height of the support member 621 is adjusted by the manual adjustment mechanism 650, the lower end position of one of the rear hanging objects 632 is made slightly lower than the lower end position of the above-mentioned middle hanging object 622, and the lower end of the other rear hanging object 632 is lowered. The position is set to be lowered further.
Therefore, the lower end positions of the first sorting member 610 in which large balls 613 are arranged in a row, the middle hanging object 622 in which medium balls 623 are arranged in a row, and the rear hanging object 632 in which small balls 633 are arranged in a row are arranged in the order of the size of the balls. ing.

さらに(図9(a)参照)、後段垂下物632は、少なくとも内周側のものは(図では手前の七連物)、小玉633の材料に鉄等の磁性体が採用されている。また、これに対応して、第2規制部材720のうち後段垂下物632に近い部位に、永久磁石などからなる引き付け部材640が嵌め込み等にて取り付けられている。そして、その引き付け力が重力の分力に加勢するため、後段垂下物632は、薬剤搬送経路の上から当接してきた薬剤に対して、穏やかながらも効果的な反力を作用させるものとなっている。これにより、第2規制部材720から離れていた薬剤が第2規制部材720に近づくので、第2規制部材720の機能が強化される。このような後段垂下物632は、自身の薬剤の高さ規制機能よりも第2規制部材720の薬剤の横幅規制の強化を重視したものとなっている。 Further (see FIG. 9(a)), at least the inner circumferential side of the rear hanging objects 632 (the seven-strand object in the front in the figure) uses a magnetic material such as iron as the material of the small beads 633. Correspondingly, an attracting member 640 made of a permanent magnet or the like is attached to a portion of the second regulating member 720 near the rear hanging object 632 by fitting or the like. Since the attractive force adds to the force of gravity, the rear hanging object 632 exerts a gentle but effective reaction force on the drug that comes into contact with it from above the drug delivery path. ing. As a result, the medicine that has been away from the second regulating member 720 approaches the second regulating member 720, so that the function of the second regulating member 720 is strengthened. Such a rear hanging object 632 emphasizes strengthening the width regulation of the medicine by the second regulating member 720 rather than its own medicine height regulation function.

特開2018-108277号公報Japanese Patent Application Publication No. 2018-108277 特許6736075号Patent No. 6736075 特願2020-012231号(出願)Patent Application No. 2020-012231 (Application)

このような薬剤フィーダでは、回転体の中に固定の整流ガイドを設ける必要が無くなるとともに種々の形状やサイズの薬剤に対する共用範囲が広がったが(背景技術1,特許文献1参照)、それに加え(背景技術2,特許文献2,3参照)、薬剤の幅を規制する後段の規制機構に高さ規制機能まで担わせたうえで、その上流に位置する仕分け部材の高さ規制機能を緩めることで、固くて丈夫な薬剤から脆い薬剤まで、更には板状といった転がり難い薬剤から球状や紡錘状といった転がり易い薬剤まで、環状回転体の上端周縁部の薬剤搬送経路で固形薬剤を無理なく一列に整列させることができるようになっている。 In such a drug feeder, there is no need to provide a fixed rectifying guide in the rotating body, and the range of common use for drugs of various shapes and sizes has expanded (see Background Art 1, Patent Document 1). (See Background Art 2, Patent Documents 2 and 3), by assigning the latter-stage regulation mechanism that regulates the width of the drug to the height regulation function, and then relaxing the height regulation function of the sorting member located upstream. , from hard and durable drugs to brittle drugs, and from drugs that are difficult to roll such as plates to drugs that are easy to roll such as spheres and spindles, solid drugs can be easily aligned in a line on the drug transport path around the upper edge of the annular rotating body. It is now possible to do so.

ところが、形状や材質の異なる種々の薬剤について長時間に及んで使用したところ、稀にではあるが、複数個の薬剤が上下に重なったままの謂わば多段薬剤が、解れにくい状態のまま、前段の仕分け部材の高さ規制を逃れて後段の規制機構に至り、規制機構の高さ規制機能によっても解されることなく、さらには規制機構の幅規制機能によって環状回転体の薬剤搬送経路から内方の傾斜回転体の上へ落とされるときに長時間を費やしたりしたときなど、それが引き金となって後に続く多数の薬剤が環状回転体の薬剤搬送経路の上に留まり続ける場合がある、ということが判明した。 However, when various drugs with different shapes and materials are used for a long time, in rare cases, so-called multi-layered drugs, in which multiple drugs are stacked one on top of the other, remain in a state that is difficult to unravel. It escapes the height regulation of the sorting member and reaches the subsequent regulation mechanism, and is not understood by the height regulation function of the regulation mechanism, and furthermore, due to the width regulation function of the regulation mechanism, the drug transport path of the annular rotating body is If a patient spends a long time being dropped onto one of the tilted rotors, this may trigger a large number of subsequent drugs to remain on the drug delivery path of the annular rotor. It has been found.

そのような渋滞状態とも言えるような状況が発生した場合、規制機構から落下排出口への薬剤搬送頻度が減少することから、薬剤の順次排出機能が予想を超えて損なわれるので処理能力が不所望な程度にまで低下したり、更には、薬剤排出検出の不所望なタイムアウトによって、フィーダ内の全薬剤の排出が完了してフィーダが空になったとの誤判定を招くことにもなりかねない。
そこで、脆い薬剤でも毀損しない範囲で且つ簡便な手法で仕分け部材の高さ規制機能を適度に回復させることが技術的な課題となる。
If such a situation that can be called a congestion situation occurs, the frequency of drug delivery from the regulating mechanism to the drop discharge port will decrease, and the sequential discharge function of drugs will be impaired more than expected, resulting in an undesirable reduction in processing capacity. Further, undesired time-out of drug discharge detection may lead to a false determination that all the drugs in the feeder have been discharged and the feeder is empty.
Therefore, a technical challenge is to restore the height regulating function of the sorting member to an appropriate level using a simple method and within a range that does not damage even fragile drugs.

本発明の薬剤フィーダは(解決手段1)、このような課題を解決するために創案されたものであり、
縦線を中心として軸回転可能な外側の環状回転体と、前記縦線から傾いた傾斜線を中心として軸回転可能な状態で前記環状回転体の内側に装備されて前記環状回転体の中空を塞ぐ傾斜回転体と、前記傾斜回転体の回転によってその上から前記環状回転体の上端周縁部の上に運ばれた固形の薬剤を前記環状回転体の回転時に整列させる仕分け部材および規制部材とを備え、前記規制部材が前記環状回転体の前記上端周縁部の上の薬剤に対して横幅を規制するようになっており、前記仕分け部材が、前記環状回転体の前記上端周縁部の上方に垂れ下がっている垂下物を具備していることにより前記環状回転体の前記上端周縁部の上の薬剤に対して高さを規制するようになっている薬剤フィーダにおいて、
前記垂下物として形状の異なる第1形の垂下物と第2形の垂下物とが設けられており、前記の第1形の垂下物が、下端部を横に押されると変形しうるものであり、前記の第2形の垂下物が、上端部を緩く支持されていて下端部を横に押されると変形せずに揺動しうるものである、ことを特徴とする。
なお、上記の縦線は、仮想のものであり、既述した鉛直線が典型的であるが、環状回転体の薬剤移送機能を損なわないほど少しなら鉛直線から傾いていても良い。
The drug feeder of the present invention (solution means 1) is invented to solve these problems,
an outer annular rotating body that is rotatable about a vertical line; and an annular rotating body that is installed inside the annular rotating body so as to be rotatable about an inclined line that is inclined from the vertical line, and is provided inside the annular rotating body to open a hollow space of the annular rotating body. a tilting rotary body for blocking, and a sorting member and a regulating member that align solid medicines carried from above onto the upper end periphery of the annular rotary body by the rotation of the tilting rotary body when the annular rotary body rotates. The regulating member is configured to regulate the width of the drug on the upper peripheral edge of the annular rotating body, and the sorting member hangs above the upper peripheral edge of the annular rotating body. In the drug feeder, the height of the drug above the upper end peripheral portion of the annular rotating body is regulated by comprising a hanging object,
A first type of hanging object and a second type of hanging object having different shapes are provided as the hanging object, and the first type of hanging object can be deformed when its lower end is pushed sideways. The second type of hanging object is characterized in that its upper end is loosely supported and can swing without being deformed when its lower end is pushed sideways.
The above-mentioned vertical line is imaginary, and the vertical line mentioned above is typical, but it may be inclined from the vertical line as long as it does not impair the drug transfer function of the annular rotating body.

また、本発明の薬剤フィーダは(解決手段2)、上記解決手段1の薬剤フィーダであって、前記の第1形の垂下物と前記の第2形の垂下物とが、前記環状回転体の周方向位置を異にしていることを特徴とする。 Further, the drug feeder of the present invention (solution means 2) is the drug feeder of the above-mentioned solution means 1, in which the first type of hanging object and the second type of hanging object are attached to the annular rotating body. It is characterized by having different positions in the circumferential direction.

さらに、本発明の薬剤フィーダは(解決手段3)、上記解決手段1,2の薬剤フィーダであって、前記の第2形の垂下物は、その全部または下端部の一部を含む部分が板状であり、この板状部分の下端面の長手方向の直線と前記環状回転体の前記上端周縁部の周方向の直線とが「ねじれの位置の直線」の関係を維持するようになっており、前記環状回転体によって移送されて前記の第2形の垂下物に当接した薬剤の移送方向が前記環状回転体の内周側へ向けられるようになっている、ことを特徴とする。 Furthermore, the drug feeder of the present invention (solution 3) is the drug feeder of the solution means 1 and 2, in which the second type of hanging object has a portion including the whole or a part of the lower end. The straight line in the longitudinal direction of the lower end surface of this plate-shaped portion and the straight line in the circumferential direction of the upper end peripheral edge of the annular rotating body maintain a relationship of "straight line at the twisting position". The medicine is characterized in that the direction of transport of the drug that has been transferred by the annular rotating body and has come into contact with the second type of hanging object is directed toward the inner circumferential side of the annular rotating body.

また、本発明の薬剤フィーダは(解決手段4)、上記解決手段1~3の薬剤フィーダであって、前記の第2形の垂下物が、並設された分離可能な複数部材からなるものである、ことを特徴とする。 Further, the drug feeder of the present invention (solution means 4) is the drug feeder of the above-mentioned solution means 1 to 3, in which the second type of hanging object is composed of a plurality of separable members arranged in parallel. characterized by something.

また、本発明の薬剤フィーダは(解決手段5)、上記解決手段1~3の薬剤フィーダであって、前記の第2形の垂下物が、分離可能な状態で並設された複数枚の同一形状の板材からなるものである、ことを特徴とする。 Further, the drug feeder of the present invention (solution means 5) is the drug feeder of the above-mentioned solution means 1 to 3, in which the second type of hanging object is a plurality of identical sheets arranged in parallel in a separable state. It is characterized by being made of shaped plate material.

このような本発明の薬剤フィーダにあっては(解決手段1)、薬剤の重なりを穏やかに解消するための垂下物として、既述した垂下物612,622,632のように下端部を横に押されると変形しうる第1形の垂下物ばかりでなく、上端部を緩く支持されていて下端部を横に押されると変形せずに揺動しうる第2形の垂下物も設けられて、両者が併用されるようになっている。何れの垂下物も、環状回転体によって搬送されて来た薬剤が当接すると、当接薬剤に対して重なりを解くような反力を作用させるが、反力の発生手段ひいては作用態様が変形と揺動とで異なることから同質の作用態様を繰り返す場合よりも多様で高い重なり解消効果を期待することができる。また、薬剤に当接した端部が揺動にて横に逃げるので、上方へ逃げるものより過剰反力が発生し難い。
したがって、この発明によれば、脆い薬剤でも毀損しない範囲で且つ簡便な手法で仕分け部材の高さ規制機能を適度に回復させることができる。
In such a drug feeder of the present invention (Solution 1), as a hanging object to gently eliminate overlapping of drugs, the lower end is placed horizontally like the hanging objects 612, 622, and 632 described above. In addition to the first type of hanging object that can be deformed when pushed, there is also a second type of hanging object that is loosely supported at its upper end and can swing without deforming when its lower end is pushed sideways. , both are now used together. When any of the hanging objects comes into contact with the drug carried by the annular rotating body, it exerts a reaction force on the contacting drug to undo the overlap, but the means for generating the reaction force and the mode of action are deformed. Since the effect differs depending on the rocking motion, it is possible to expect a more diverse and higher overlap elimination effect than when the same mode of action is repeated. In addition, since the end that has come into contact with the medicine oscillates and escapes laterally, excessive reaction force is less likely to occur than when it escapes upward.
Therefore, according to the present invention, the height regulating function of the sorting member can be restored to an appropriate level within a range that does not damage even brittle drugs and in a simple manner.

また、本発明の薬剤フィーダにあっては(解決手段2)、第1形の垂下物と第2形の垂下物とを環状回転体の周方向に分散して設けたことで、複数の垂下物を何れも薬剤搬送経路上に無理なく配置することができるばかりか、態様の異なる複数種類の作用すなわちタイプの異なる「重畳薬剤の解し作用」を時間差を持って働かせることで、両作用が相殺しあうといった不所望な事態を、簡便に回避することもできる。 In addition, in the drug feeder of the present invention (solution means 2), the first type of hanging objects and the second type of hanging objects are distributed in the circumferential direction of the annular rotating body, so that a plurality of hanging objects are provided. Not only can any object be placed on the drug delivery route without any difficulty, but by having multiple types of effects with different modes, that is, different types of ``releasing effects of superimposed drugs'' working at different times, both effects can be achieved. It is also possible to easily avoid undesirable situations such as canceling each other out.

さらに、本発明の薬剤フィーダにあっては(解決手段3)、第2形の垂下物について少なくとも下端部の形状は板状にしたうえで、この板状部分の下端の長手方向の向きを直下の薬剤移送方向に対して傾斜させておくとともに、その傾斜が第2形の垂下物の揺動によって変動する範囲を限定しておくという簡便な手法によって、他の薬剤の上に乗った状態で移送されてきた薬剤の移送方向が、第2形の垂下物との当接によって環状回転体の内周側へ変えられるので、簡便な構成でも重畳薬剤の解し作用と余剰薬剤の戻し作用とが強化される。 Furthermore, in the drug feeder of the present invention (solution means 3), at least the lower end of the second type of hanging object is made into a plate shape, and the longitudinal direction of the lower end of this plate-shaped part is directed directly below the lower end. By using a simple method of tilting the drug with respect to the direction of drug transfer and limiting the range in which the inclination changes due to the swinging of the second type of hanging object, the drug can be placed on top of other drugs. The direction of transport of the transferred drug is changed to the inner circumferential side of the annular rotating body by contact with the second hanging object, so even with a simple configuration, the action of loosening the superimposed drug and returning the excess drug can be achieved. will be strengthened.

また、本発明の薬剤フィーダにあっては(解決手段4)、分離可能な複数部材を並設して第2形の垂下物としたことにより、薬剤当接時に複数部材が僅かながらもズレたり細かく離接したりもすることから、薬剤に対する反力について総量が同じでもピークは下がる傾向が見られるので、薬剤への不所望な衝撃等を抑制しつつ重畳薬剤の解し作用を強化することができる。 In addition, in the drug feeder of the present invention (Solution 4), by arranging a plurality of separable members in parallel to form a second type of hanging object, the plurality of members do not shift slightly when the drug comes into contact with them. Since the reaction force against the drug tends to decrease even if the total amount is the same, it is possible to strengthen the dissolving action of the superimposed drug while suppressing undesirable impact on the drug. can.

また、本発明の薬剤フィーダにあっては(解決手段5)、分離可能な複数部材の並設により上記解決手段4の作用効果を奏することに加え、板材形状の同一化により製造負担が軽減されるとともに、同一形状の複数板材の並設により稠密配置まで容易に行える。 In addition, in the drug feeder of the present invention (solution 5), in addition to achieving the effects of solution 4 by arranging a plurality of separable members in parallel, the manufacturing burden is reduced by making the plate shapes the same. In addition, dense arrangement can be easily achieved by arranging multiple plates of the same shape side by side.

本発明の実施例1について、薬剤フィーダの要部の構造を示し、(a)が仕分け機構とその周辺部とに係る外観斜視図であり、(b)が仕分け機構だけの外観斜視図である。Regarding Example 1 of the present invention, the structure of the main part of the drug feeder is shown, (a) is an external perspective view of the sorting mechanism and its surroundings, and (b) is an external perspective view of only the sorting mechanism. . 単体の中段垂下物に係る平面図と正面図と右側面図と背面図と左側面図である。They are a plan view, a front view, a right side view, a back view, and a left side view of a single intermediate hanging object. 複数並設の中段垂下物に係る平面図と正面図と右側面図と背面図と左側面図である。They are a plan view, a front view, a right side view, a rear view, and a left side view of a plurality of middle-stage hanging objects arranged side by side. 薬剤フィーダの動作状態を示し、(a)が薬剤を仕分けしている仕分け機構などに係る外観斜視図であり、(b)が仕分け機構の中段垂下物の斜交当接面による仕分け状況をしめす外観斜視図である。It shows the operating state of the drug feeder, and (a) is an external perspective view of the sorting mechanism that sorts drugs, and (b) shows the sorting situation by the diagonal contact surfaces of the middle hanging objects of the sorting mechanism. It is an external perspective view. 薬剤を仕分けしている中段垂下物の揺動状態などを示し、(a)が平面図、(b)が正面図である。It shows the swinging state of the middle-stage hanging object for sorting medicines, and (a) is a plan view, and (b) is a front view. 背景技術1の欄で説明した薬剤フィーダの要部構造を示し、(a)が平面図、(b)が縦断正面図である。1 shows the main structure of the medicine feeder described in the section of Background Art 1, in which (a) is a plan view and (b) is a longitudinal sectional front view. 背景技術2の欄で説明した薬剤フィーダの要部構造を示す縦断正面図である。FIG. 2 is a longitudinal sectional front view showing the main structure of the drug feeder described in the section of Background Art 2. FIG. その薬剤フィーダの規制機構の構造を示し、(a)が大きめの型用薬剤を型置場に置いたときの平面図、(b)が第1規制部材に係る平面図と端面図である。The structure of the regulation mechanism of the chemical feeder is shown, and (a) is a plan view when a larger molding chemical is placed in the mold storage area, and (b) is a plan view and an end view of the first regulating member. その薬剤フィーダの仕分け機構の構造を示し、(a)が仕分け機構とその設置先部分とに係る斜視図、(b)が第1仕分け部材の正面図、(c)が第2仕分け部材の正面図である。The structure of the sorting mechanism of the drug feeder is shown, in which (a) is a perspective view of the sorting mechanism and its installation location, (b) is a front view of the first sorting member, and (c) is a front view of the second sorting member. It is a diagram.

このような本発明の薬剤フィーダについて、これを実施するための具体的な形態を、以下の実施例1により説明する。
図1~5に示した実施例1は、上述した解決手段1~5(出願当初の請求項1~5)を総て具現化したものである。
なお、それらの図示に際しては、簡明化等のため、背景技術欄において既述したものや同等品で足りる部材等については図示を割愛し、発明の説明に必要なものや関連するものを中心に図示した。
また、それらについて背景技術の欄で述べたことと重複するものについては、繰り返しとなる説明を割愛し、以下、従来との相違点を中心に説明する。
A specific form for implementing the drug feeder of the present invention will be described with reference to Example 1 below.
Embodiment 1 shown in FIGS. 1 to 5 embodies all of the above-mentioned solutions 1 to 5 (claims 1 to 5 originally filed).
In addition, for the sake of simplification, etc., when illustrating these figures, we omit the illustrations of those already described in the background art column or those for which equivalent products are sufficient, and focus on those necessary for explaining the invention or those related to it. Illustrated.
Further, for those that overlap with those described in the background art section, repeated explanations will be omitted, and the following will mainly explain the differences from the conventional technology.

本発明の薬剤フィーダの実施例1について、その具体的な構成を、図面を引用して説明する。図1は、薬剤フィーダ1100の要部の構造を示し、(a)が仕分け機構1600とその周辺部とに係る外観斜視図であり、(b)が仕分け機構1600だけの外観斜視図である。また、図2は、単体の中段垂下物1623に係る平面図と正面図と右側面図と背面図と左側面図であり、図3は、二個の中段垂下物1623,1623を隣り合わせ状態で並設した中段垂下物1622に係る平面図と正面図と右側面図と背面図と左側面図である。 The specific configuration of Example 1 of the drug feeder of the present invention will be described with reference to the drawings. FIG. 1 shows the structure of the main parts of the medicine feeder 1100, in which (a) is an external perspective view of the sorting mechanism 1600 and its surroundings, and (b) is an external perspective view of only the sorting mechanism 1600. 2 is a plan view, a front view, a right side view, a rear view, and a left side view of the single middle-stage hanging object 1623, and FIG. They are a plan view, a front view, a right side view, a rear view, and a left side view of the middle hanging objects 1622 arranged in parallel.

薬剤フィーダ1100は(図1参照)、適宜改良されながらも所要の機能を維持する態様で全体的な概要構成部分を既述の薬剤フィーダ10,100(図6,図7参照)から踏襲しており(図1(a)参照)、既述した筐体の周壁11を踏襲した筐体の周壁1011と、既述の環状回転体20を踏襲していて縦線を中心として軸回転可能な外側の環状回転体1020と、既述の傾斜回転体30を踏襲していて上記の縦線から傾いた傾斜線を中心として軸回転可能な状態で環状回転体1020の内側に装備されて環状回転体1020の中空を塞ぐ傾斜回転体1030とを備えている。 The drug feeder 1100 (see FIG. 1) follows the general structure of the previously described drug feeders 10 and 100 (see FIGS. 6 and 7) in a manner that maintains the required functions while appropriately improving the drug feeder 1100. (see FIG. 1(a)), a peripheral wall 1011 of the casing that follows the peripheral wall 11 of the casing already described, and an outer side that follows the annular rotating body 20 described above and is rotatable around a vertical line. An annular rotating body 1020 that follows the above-mentioned inclined rotating body 30 and is equipped inside the annular rotating body 1020 so as to be rotatable around an inclined line inclined from the above-mentioned vertical line. The tilting rotating body 1030 closes the hollow of 1020.

また、薬剤フィーダ1100は(図1(a)参照)、傾斜回転体1030の回転によって傾斜回転体1030の上から環状回転体1020の上端周縁部23の上へ運び上げられた固形の薬剤を環状回転体1020の回転時に整列させる仕分け機構1600および規制機構1700も備えている。
後者の規制機構1700は、規制対象の横幅を電動にて可変調整できるようになっていることを含む幾つかの改造が施されているが、基本的な構造部分は既述の規制機構700を踏襲しており、環状回転体1020の上端周縁部23の上の薬剤搬送経路に対して横幅を規制するとともに薬剤に対する最終的な高さ規制も行うようになっている。
Further, the drug feeder 1100 (see FIG. 1(a)) carries the solid drug carried up from above the inclined rotating body 1030 onto the upper end peripheral portion 23 of the annular rotating body 1020 by the rotation of the inclined rotating body 1030 into an annular shape. It also includes a sorting mechanism 1600 and a regulating mechanism 1700 that align the rotating body 1020 when it rotates.
The latter regulation mechanism 1700 has been modified in some ways, including the ability to electrically adjust the width of the regulation target, but its basic structure is the same as that of the regulation mechanism 700 described above. In addition to regulating the width of the drug transport path above the upper peripheral edge 23 of the annular rotating body 1020, the final height of the drug is also controlled.

仕分け機構1600は(図1(a)の散点模様部分,図1(b)参照)、環状回転体1020の上端周縁部23の上の薬剤に対して通過可能な高さを厳密でなく多少なら漏れがあっても良いから穏やかに規制するためのものであり、環状回転体1020の上端周縁部23の上方に垂れ下がる垂下物として、大玉613を縦に連ねて曲折自在な既述の前段垂下物612と、後で詳述する板状の中段垂下物1623を二枚横並びさせた中段垂下物1622と、小玉633を縦に連ねて曲折自在な後段垂下物632という三種類の垂下物を具備している。それら612,1622,632は、その順で上端周縁部23の上流から下流へと配設されており、何れも上端周縁部23(薬剤搬送経路)の上方に位置しつつも、環状回転体1020の周方向位置を異にするものとなっている。 The sorting mechanism 1600 (see the scattered dot pattern part in FIG. 1(a) and FIG. 1(b)) does not set the height at which the drug above the upper end peripheral portion 23 of the annular rotating body 1020 can pass, but rather has a certain height. If so, this is to gently control leakage even if there is leakage, and as a hanging object that hangs down above the upper end peripheral portion 23 of the annular rotating body 1020, the large balls 613 are vertically connected and the bendable front stage hanging is used. It is equipped with three types of hanging objects: a middle hanging object 1622, which is made up of two plate-like middle hanging objects 1623 arranged side by side, and a bendable rear hanging object 632, which has small beads 633 arranged vertically. are doing. These 612, 1622, and 632 are arranged in that order from upstream to downstream of the upper end peripheral edge 23, and are all located above the upper end peripheral edge 23 (medicine transport path), but are not connected to the annular rotating body 1022. The positions in the circumferential direction are different.

複数の前段垂下物612を吊り下げ保持する支持部材1611は短めであるのに対し、中段垂下物1622と後段垂下物632とを吊り下げ保持する支持部材1621は長めで規制機構1700を跨いでいるが、両部材1611,1621は一体物から作られているので或いは緊結されているので、支持部材1611を含む第1仕分け部材1610と支持部材1621を含む第2仕分け部材1620も一体化している。
そのため、図示は割愛したが電動モータ等にて三種の垂下物612,1622,632の下端位置を纏めて上下に自動調整することができるようにもなっている。また、それら三種の垂下物が不要なときには纏めて取り外すことができ、着脱が容易である。
The support member 1611 that suspends and holds the plurality of front-stage hanging objects 612 is short, whereas the support member 1621 that suspends and holds the middle-stage hanging objects 1622 and the rear-stage hanging objects 632 is long and straddles the regulating mechanism 1700. However, since both members 1611 and 1621 are made of one piece or are tightly connected, the first sorting member 1610 including the supporting member 1611 and the second sorting member 1620 including the supporting member 1621 are also integrated.
Therefore, although not shown in the drawings, the lower end positions of the three types of hanging objects 612, 1622, and 632 can be automatically adjusted up and down using an electric motor or the like. Moreover, when these three types of hanging objects are not needed, they can be removed all at once, making attachment and detachment easy.

また、玉を曲折自在に繋げた前段垂下物612と後段垂下物632は、既述したように、環状回転体1020の上端周縁部23によって搬送されて来た薬剤がそれら612,632の下端部に衝突して横に押されると、衝突薬剤を押しとどめつつも衝撃は緩和するために、全体的には弓なりになり、下端部ほど容易に大きく変形する第2形の垂下物と言えるものになっている。 In addition, as described above, the front hanging object 612 and the rear hanging object 632, in which the balls are connected in a bendable manner, allow the medicine conveyed by the upper peripheral edge 23 of the annular rotating body 1020 to reach the lower ends of these 612, 632. When it collides with an object and is pushed sideways, it becomes a type 2 hanging object, in which the object becomes arched overall and deforms more easily toward the lower end, in order to suppress the collision agent and soften the impact. It has become.

これに対し、縦に細長い板状体からなり変形しづらい中段垂下物1623は、その上端部1623aが支持部材1621の貫通孔1621aの所に遊嵌状態で引っ掛けられて緩く吊持されているので、下端部を横に押されると変形せずに揺動しうる単体の第2形の垂下物と言える。
また、この中段垂下物1623を二枚(複数枚)ほど密だが分離容易な状態で横に並べた中段垂下物1622は、複数並設の第2形の垂下物と言えるものであり、前段垂下物612や後段垂下物632とは変形状況ひいては複数薬剤の重なり解し作用の内容が異なるものとなっている。
On the other hand, the middle hanging object 1623, which is a vertically elongated plate and is difficult to deform, has its upper end 1623a hooked loosely into the through hole 1621a of the support member 1621, so that it is loosely suspended. , it can be said to be a single, second-type hanging object that can swing without deforming when its lower end is pushed sideways.
Furthermore, the middle-stage hanging objects 1622, in which two (multiple) middle-stage hanging objects 1623 are arranged side by side in a dense but easy-to-separate state, can be said to be a second type of hanging objects in which a plurality of middle-stage hanging objects are arranged side by side. The object 612 and the downstream hanging object 632 are different from each other in the deformation state and the contents of the overlapping action of multiple drugs.

さらに、支持部材1621による中段垂下物1622の保持状態を説明すると(図1(b),図2,図3参照)、下端部を振る揺動については、衝撃緩和のため比較的大きめに許容されるが、仮想の縦軸を中心にして回る謂わば自転状回転については、二枚の中段垂下物1623の下端部1623cのうち薬剤当接対象となる前側の下端部1623cの斜交当接面1623dが当接薬剤に押されたときにその向きが過剰に変動するのを防止するために、例えば中段垂下物1623の上端部1623aと貫通孔1621aとの間隙が適度に抑制されたスリット状に形成されていて、上記の自転状回転の揺れ幅が小さく抑えられるようになっている。 Furthermore, explaining the state in which the middle hanging object 1622 is held by the support member 1621 (see FIG. 1(b), FIG. 2, and FIG. 3), the swinging motion of the lower end is allowed to be relatively large in order to reduce the impact. However, regarding the so-called autorotation that revolves around an imaginary vertical axis, the oblique contact surface of the front lower end 1623c of the lower end 1623c of the two middle hanging objects 1623 that is the object of drug contact. In order to prevent the direction of 1623d from changing excessively when it is pressed by the abutting agent, the gap between the upper end 1623a of the middle hanging object 1623 and the through hole 1621a is appropriately suppressed, for example, in the form of a slit. The width of the oscillation caused by the above-mentioned autorotation can be suppressed to a small level.

中段垂下物1623の典型的な構成例は(図2参照)、縦長の平板部1623eと、その上端から少しだけ突き出た上端部1623aと、縦長平板部1623eの中央部から上端部1623aと同じ方向に突き出た中央部1623bと、縦長平板部1623eの下端部から長めに突き出た下端部1623cとを具えている。縦長平板部1623eと上端部1623aと中央部1623bは一つの平面に属している。これに対し、下端部1623cは、上端部1623aや中央部1623bと同様に縦長平板部1623dの両側のうち同じ側へ突き出ているが、全く同じ方向でなく、横へ約30゜ほど傾いている。 A typical configuration example of the middle hanging object 1623 (see FIG. 2) includes a vertically long flat plate part 1623e, an upper end part 1623a that slightly protrudes from the upper end of the vertically long flat plate part 1623e, and an upper end part 1623a extending from the center of the vertically long flat plate part 1623e in the same direction as the upper end part 1623a. It has a central portion 1623b that protrudes from above, and a lower end portion 1623c that protrudes longer from the lower end of the vertically long flat plate portion 1623e. The vertically long flat plate portion 1623e, the upper end portion 1623a, and the center portion 1623b belong to one plane. On the other hand, the lower end portion 1623c protrudes toward the same side of both sides of the vertically long flat plate portion 1623d like the upper end portion 1623a and the center portion 1623b, but it is not in exactly the same direction and is tilted laterally by about 30 degrees. .

中段垂下物1622は(図3参照)、上述した中段垂下物1623を二枚ほど重ね合わせたものであり、支持部材1621に上端部を取り付けられた状態で、二枚の大部分がぴったり重なった状態で、環状回転体1020の上端周縁部23の上方に垂れ下がり、二枚の中段垂下物1623の下端部1623cのうち一方が薬剤5の当接を受ける斜交当接面1623dになる。その垂下状態では、斜交当接面1623dの下辺と重なる直線(板状部分の下端面の長手方向の直線)と、環状回転体1020の上端周縁部23の周方向の直線とが、上下から見ると交差しているかのように見えるが横から見ると離れて見える「ねじれの位置の直線」の関係を維持するようになっている。 The middle hanging object 1622 (see FIG. 3) is made by overlapping two pieces of the middle hanging object 1623 described above, and with the upper end attached to the support member 1621, most of the two pieces overlap exactly. In this state, it hangs above the upper peripheral edge 23 of the annular rotating body 1020, and one of the lower ends 1623c of the two middle hanging objects 1623 becomes an oblique contact surface 1623d that receives the medicine 5. In the hanging state, a straight line that overlaps with the lower side of the oblique contact surface 1623d (a straight line in the longitudinal direction of the lower end surface of the plate-shaped portion) and a straight line in the circumferential direction of the upper end peripheral portion 23 of the annular rotating body 1020 are When viewed from the side, they appear to intersect, but when viewed from the side, they appear to be separated, maintaining a ``straight line at the twist position'' relationship.

この実施例1の薬剤フィーダ1100について、その使用態様及び動作を、図面を引用して説明する。図4は、薬剤フィーダ1100の動作状態、そのなかでも特に仕分け機構1600の動作状態を示しており、(a)が、薬剤5のうち中段垂下物1622の所に来た薬剤5b,5cを仕分けしている仕分け機構1600などに係る外観斜視図であり、(b)が、仕分け機構1600の中段垂下物1622の斜交当接面1623dによる仕分け状況をしめす外観斜視図である。また、図5は、薬剤5b,5cを仕分けしている中段垂下物1622の揺動状態などを示し、(a)が平面図、(b)が正面図である。 The usage and operation of the drug feeder 1100 of Example 1 will be explained with reference to the drawings. FIG. 4 shows the operating state of the drug feeder 1100, especially the operating state of the sorting mechanism 1600, in which (a) shows the sorting of the drugs 5b and 5c that have arrived at the middle hanging object 1622 among the drugs 5. FIG. 3B is an external perspective view of the sorting mechanism 1600 and the like, and FIG. Moreover, FIG. 5 shows the swinging state of the middle hanging object 1622 that sorts the medicines 5b and 5c, and FIG. 5(a) is a plan view and FIG. 5(b) is a front view.

薬剤フィーダ1100を使用するに先だち、仕分け機構1600については、薬剤5の厚み等に応じた高さ調整を済ませておくことが必要であり、具体的には(図4参照)、薬剤5一個分の高さよりは高いが薬剤5二個分の高さよりは低いところに中段垂下物1622の下端が来るように、第1,第2仕分け部材1610,1620を昇降させておく。
その昇降調整は、図示しないコントローラやその上位の管理装置などに予めデータ設定された薬剤5の厚み測定値などに基づき図示しない電動モータ等利用の自動制御にて行われる。なお、薬剤が初めて取り扱うものの場合は薬剤5の厚み測定やデータ設定も先に済ませておく。
Before using the drug feeder 1100, it is necessary to adjust the height of the sorting mechanism 1600 according to the thickness of the drug 5, etc. (see FIG. 4). The first and second sorting members 1610 and 1620 are raised and lowered so that the lower end of the middle hanging object 1622 is higher than the height of , but lower than the height of 5 two medicines.
The vertical adjustment is performed by automatic control using an electric motor (not shown) or the like based on the thickness measurement value of the drug 5 that is set in advance in a controller (not shown) or a superordinate management device (not shown). In addition, if the drug is handled for the first time, the thickness measurement and data setting of the drug 5 should also be completed first.

そして、必要数かそれ以上の多数の薬剤5を薬剤フィーダ1100に投入し、具体的には環状回転体1020に囲まれた傾斜回転体1030の上に投入し、そうしてから、薬剤フィーダ1100を作動させると、薬剤5が、次々に、傾斜回転体1030によって持ち上げられて環状回転体1020の上端周縁部23(薬剤搬送経路)の上に載り移り(図4(a)参照)、環状回転体1020の回転に伴って前段垂下物612と中段垂下物1623と後段垂下物632の順にその下を潜り抜けようとする。 Then, a large number of medicines 5, the required number or more, are put into the medicine feeder 1100, specifically onto the tilted rotary body 1030 surrounded by the annular rotary body 1020, and then the medicine feeder 1100 is When activated, the medicines 5 are lifted one after another by the tilting rotary body 1030 and placed on the upper edge portion 23 (drug transport path) of the annular rotary body 1020 (see FIG. 4(a)), and the annular rotation As the body 1020 rotates, the front hanging object 612, the middle hanging object 1623, and the rear hanging object 632 try to pass under them in this order.

そのとき、重なり合うことなく単独で上端周縁部23に載っている薬剤5は、前後の垂下物612,632とはほとんど干渉することなく干渉したとしても上端周縁部23の上で僅かに移動する程度にとどまり、中間の中段垂下物1623とは全く干渉することなく、それらの下を通過する。
これに対し、上下に重なった薬剤5b,5cについては(図4(a)参照)、上側の薬剤5bが、前段垂下物612に当接し、その反力で重なりを崩されることもあるが、下端部を横に押されると変形しうる前段垂下物612の当たりは薬剤5を傷つけないように弱めになっているので、重なりが崩れず残ることもある。
At this time, the medicine 5 that is placed alone on the upper edge 23 without overlapping hardly interferes with the hanging objects 612 and 632 in front and behind, and even if it does interfere, it will only move slightly on the upper edge 23. , and passes under the intermediate hanging object 1623 without interfering with it at all.
On the other hand, for the drugs 5b and 5c stacked one above the other (see FIG. 4(a)), the upper drug 5b may come into contact with the front hanging object 612, and the overlapping may be broken by the reaction force. The front hanging object 612, which can deform when the lower end is pushed sideways, has a weak contact so as not to damage the drug 5, so the overlap may remain intact.

そして、そのように上下に重なったまま前段垂下物612を通過した薬剤5b,5cが中段垂下物1622のところへ運ばれて来ると(図4参照)、上側の薬剤5bが、中段垂下物1622の下端部1623cの斜交当接面1623dに当接し、その反力によって前方への直進を拒まれることから、下端部1623cの斜交当接面1623dや縦長平板部1623eの表面に沿うようして移動する。
このように上側の薬剤5bの進行方向が環状回転体1020の内周側へ向けられるため、環状回転体1020の上端周縁部23から内側へ進んで、上側の薬剤5bは、傾斜回転体1030の上へ落下することが多い(図4(b)一点鎖線を参照)。
Then, when the drugs 5b and 5c that have passed through the front hanging object 612 while stacked vertically are brought to the middle hanging object 1622 (see FIG. 4), the upper drug 5b is transferred to the middle hanging object 1622. Because it comes into contact with the diagonal contact surface 1623d of the lower end 1623c and is prevented from moving straight forward due to the reaction force, the and move.
In this way, since the traveling direction of the upper drug 5b is directed toward the inner circumferential side of the annular rotating body 1020, the upper drug 5b advances inward from the upper end peripheral portion 23 of the annular rotating body 1020, and the upper drug 5b is directed toward the inner peripheral side of the annular rotating body 1020. They often fall upward (see the dashed line in Figure 4(b)).

下側の薬剤5bは、中段垂下物1622の下を潜って通過することが多いが、薬剤5cに随伴して環状回転体1020の上端周縁部23から落下することもある。
中段垂下物1622は、下端部を横に押されても変形しないものなので、薬剤5b,5cの重なりを解す能力は他の垂下物612,632より優れているが、それでも薬剤を傷つけないために薬剤との当接時の衝撃やその後の圧力を揺動することで緩和するようになっているので、稀には薬剤5b,5cが重なったまま中段垂下物1622を押しのけて通過することもある。
The lower medicine 5b often passes under the middle hanging object 1622, but it may fall from the upper end peripheral edge 23 of the annular rotating body 1020 along with the medicine 5c.
The middle hanging object 1622 does not deform even if its lower end is pushed sideways, so it has a better ability to break up the overlap between the drugs 5b and 5c than the other hanging objects 612 and 632. However, in order not to damage the drugs, Since the shock at the time of contact with the drug and the subsequent pressure are alleviated by swinging, in rare cases, the drugs 5b and 5c may push aside the middle hanging object 1622 while still being overlapped. .

その場合、後段垂下物632による穏やかな重なり解し作用が施され、それでも崩れなかった場合だけ、薬剤5b,5cの重なりに対し、既述した後方の規制機構700によって、緩やかな高さ規制に加え、環状回転体1020の上端周縁部23の薬剤搬送経路の幅を外周側から狭める横幅規制も、作用する。
そのため、薬剤5b,5cの重なりが解消されるか、薬剤5b,5cが重なったまま環状回転体1020の上端周縁部23の上から傾斜回転体1030の上へ強制移動させられるので、薬剤の重なりが薬剤搬送経路から落下排出口14へ送り込まれることはない。
In that case, a gentle overlapping action is performed by the rear hanging object 632, and only if the medicines 5b and 5c do not collapse, the rear regulating mechanism 700 described above gently regulates the height of the overlapping medicines 5b and 5c. In addition, the width restriction that narrows the width of the drug transport path of the upper end peripheral edge portion 23 of the annular rotating body 1020 from the outer peripheral side also works.
Therefore, the overlapping of the drugs 5b and 5c is eliminated, or the drugs 5b and 5c are forcibly moved from above the upper end peripheral portion 23 of the annular rotating body 1020 to above the inclined rotating body 1030 while remaining overlapped, so that the overlapping of the drugs is eliminated. is not sent from the drug transport path to the drop outlet 14.

さらに、二枚の中段垂下物1623を密接配置してなる一組の中段垂下物1622の作動について説明すると(図5参照)、環状回転体1020による薬剤5b,5cの重なりの進行方向(二点鎖線を参照)に対して当接干渉部分が傾斜しているため、詳しくは、中段垂下物1622の斜交当接面1623d(当接面および前半の倣い面)は角度θ1ほど傾いているのに対し、中段垂下物1622の縦長平板部1623e(後半の倣い面)は角度θ2しか傾いておらず、角度θ1が角度θ2より大きいので(θ1>θ2)、中段垂下物1622に当接した薬剤5b,5cの重なりに対し、前半には強めの崩し力が作用し、後半には環状回転体1020の上から傾斜回転体1030の上へ薬剤5bを追い出す力が強化されるので、薬剤の重なりが薬剤搬送経路から無くなる割合が高まる。 Furthermore, to explain the operation of a pair of middle-stage hanging objects 1622 formed by closely arranging two middle-stage hanging objects 1623 (see FIG. 5), the traveling direction of the overlapping of drugs 5b and 5c by the annular rotating body 1020 (two points In detail, the oblique contact surface 1623d (contact surface and first half copying surface) of the middle hanging object 1622 is inclined at an angle of θ1. On the other hand, the vertically long flat plate portion 1623e (second half tracing surface) of the middle hanging object 1622 is tilted only at the angle θ2, and since the angle θ1 is larger than the angle θ2 (θ1>θ2), the drug that has come into contact with the middle hanging object 1622 With respect to the overlap between 5b and 5c, a strong breaking force is applied in the first half, and in the second half, the force to expel the drug 5b from above the annular rotating body 1020 onto the inclined rotating body 1030 is strengthened, so that the overlap of the drugs is reduced. The rate at which the drug disappears from the drug delivery route increases.

しかも、中段垂下物1622を成す複数枚の中段垂下物1623,1623が自由状態では密に接しているが(図1(b),図3参照)、それら1623,1623は分離可能なものなので、斜交当接面1623dに薬剤5bが当接したときには(図5参照)、上端部1623aはほとんど移動しないで下端部1623c(1623d)が揺動するのに加え、同時に微細な摺動や離接を繰り返すことも行うので、当接時の衝撃やその後の摩擦力なども低減緩和されることになる。
こうして、薬剤5b,5cの重なりが高い確度で無理なく解消される。
Moreover, although the plurality of middle-stage hanging objects 1623, 1623 forming the middle-stage hanging object 1622 are in close contact with each other in the free state (see FIGS. 1(b) and 3), they can be separated. When the drug 5b comes into contact with the diagonal contact surface 1623d (see FIG. 5), the upper end 1623a hardly moves and the lower end 1623c (1623d) swings, and at the same time there is slight sliding or separation. Since this is also repeated, the impact at the time of contact and the subsequent frictional force are also reduced and alleviated.
In this way, the overlap between the drugs 5b and 5c can be easily eliminated with high accuracy.

[その他]
上記実施例では、仕分け機構1600のうち、第2仕分け部材1620の支持部材1621部分だけが跨ぎ仕分け部材になっており、第1仕分け部材1610の支持部材1611は跨ぎ仕分け部材になっていなかったが、これは必須でなく、第1仕分け部材1610の支持部材1611まで跨ぎ仕分け部材になっていても良い。
[others]
In the above embodiment, in the sorting mechanism 1600, only the support member 1621 portion of the second sorting member 1620 is a straddling sorting member, and the supporting member 1611 of the first sorting member 1610 is not a straddling sorting member. , this is not essential, and the sorting member may straddle the support member 1611 of the first sorting member 1610.

本発明の薬剤フィーダは、錠剤分包機に搭載された多数の整列盤回転タイプ薬剤フィーダのうち一部のもの或いは全部を代替するのに用いても良く、薬剤フィーダを一個か少数個しか搭載しない錠剤分割器に搭載しても良く、さらには薬瓶へ錠剤等の薬剤を充填する装置などにおいて逐次送出した薬剤の個数を数え上げる錠剤カウンタ(薬剤カウンタ)などに搭載しても良い。 The drug feeder of the present invention may be used to replace some or all of the many rotating alignment plate type drug feeders installed in a tablet packaging machine, and only one or a small number of drug feeders are installed. It may be mounted on a tablet splitter, or furthermore, it may be mounted on a tablet counter (drug counter) that counts the number of medicines sequentially delivered in a device that fills medicines such as tablets into medicine bottles.

5,5a,5b 薬剤
10…薬剤フィーダ、
11…周壁、12…搬送面ガイド、13…排出ガイド、14…落下排出口、
20…環状回転体、21…下部、22…上部、23…上端周縁部(薬剤搬送経路)、
30…傾斜回転体、31…中央突起、32…央部、33…周縁部、
20+30…回転容器、
40…支承機構、41…受動部材、
42…大径部外装回転伝動部材、43…小径部外装回転伝動部材、
50…回転駆動機構、51…回転駆動部材、
54…回転駆動モータ、54a,54b…回転駆動モータ、
55…傾斜回転体装着検出手段、56…薬剤落下検出手段、
60…仕分け部材、61…基端部、62…先端部(薬剤当接部位)、63…支持部、
70…規制機構、71…第1規制部材、72…第2規制部材、
73…リンク機構、74…型置場、
100…薬剤フィーダ、
600…仕分け機構、
610…第1仕分け部材、611…支持部材、
612…前段垂下物(第1形の垂下物)、613…大玉、
620…第2仕分け部材(跨ぎ仕分け部材)、621…支持部材(跨ぎ部)、
622…中段垂下物(横並び垂下物,第1形の垂下物)、623…中玉、
632…後段垂下物(横並び垂下物,第1形の垂下物)、633…小玉、
640…引き付け部材、650…手動調整機構、
651…下限設定機構、652…目盛部材、
700…規制機構、
710…第1規制部材、711…下段部分、
712…上段部分、720…第2規制部材、
1100…薬剤フィーダ、
1011…周壁、1020…環状回転体、1030…傾斜回転体、
1600…仕分け機構、
1610…第1仕分け部材、1611…支持部材、
1620…第2仕分け部材(跨ぎ仕分け部材)、
1621…支持部材(跨ぎ部)、1621a…貫通孔(揺動認容指示部)、
1622…中段垂下物(複数並設の第2形の垂下物)、
1623…中段垂下物(単体の第2形の垂下物)、
1623a…上端部、1623b…中央部、1623c…下端部、
1623d…斜交当接面、1623e…縦長平板部、
1700…規制機構
5, 5a, 5b Drug 10...Drug feeder,
DESCRIPTION OF SYMBOLS 11... Peripheral wall, 12... Conveyance surface guide, 13... Discharge guide, 14... Fall discharge port,
20... Annular rotating body, 21... Lower part, 22... Upper part, 23... Upper end peripheral part (drug transport path),
30... Inclined rotating body, 31... Central projection, 32... Center part, 33... Peripheral part,
20+30...Rotating container,
40...Support mechanism, 41...Passive member,
42... Large diameter portion exterior rotation transmission member, 43... Small diameter portion exterior rotation transmission member,
50... Rotation drive mechanism, 51... Rotation drive member,
54... Rotation drive motor, 54a, 54b... Rotation drive motor,
55...Inclination rotating body attachment detection means, 56...Medicine falling detection means,
60... sorting member, 61... proximal end, 62... distal end (drug contact area), 63... support part,
70...Regulation mechanism, 71...First regulation member, 72...Second regulation member,
73...Link mechanism, 74...Mold storage area,
100...Drug feeder,
600...sorting mechanism,
610...first sorting member, 611...supporting member,
612... Front stage hanging object (first type hanging object), 613... Large ball,
620...Second sorting member (straddling sorting member), 621...Supporting member (straddling part),
622...Middle stage hanging object (horizontal hanging object, first type hanging object), 623...Medium ball,
632...Later hanging item (horizontal hanging item, first type hanging item), 633...Small ball,
640...Attraction member, 650...Manual adjustment mechanism,
651...lower limit setting mechanism, 652...scale member,
700...regulatory organization,
710...first regulating member, 711...lower section,
712...Upper stage portion, 720...Second regulation member,
1100...Drug feeder,
1011... Peripheral wall, 1020... Annular rotating body, 1030... Inclined rotating body,
1600...sorting mechanism,
1610...first sorting member, 1611...support member,
1620...second sorting member (straddle sorting member),
1621...Supporting member (straddling part), 1621a...Through hole (swing acceptance instruction part),
1622...Middle stage hanging object (second type hanging object installed in parallel),
1623...Middle stage hanging object (single second type hanging object),
1623a...upper end, 1623b...center, 1623c...lower end,
1623d...Oblique contact surface, 1623e...Vertical flat plate part,
1700...Regulatory organization

Claims (5)

縦線を中心として軸回転可能な外側の環状回転体と、前記縦線から傾いた傾斜線を中心として軸回転可能な状態で前記環状回転体の内側に装備されて前記環状回転体の中空を塞ぐ傾斜回転体と、前記傾斜回転体の回転によってその上から前記環状回転体の上端周縁部の上に運ばれた固形の薬剤を前記環状回転体の回転時に整列させる仕分け部材および規制部材とを備え、前記規制部材が前記環状回転体の前記上端周縁部の上の薬剤に対して横幅を規制するようになっており、前記仕分け部材が、前記環状回転体の前記上端周縁部の上方に垂れ下がっている垂下物を具備していることにより前記環状回転体の前記上端周縁部の上の薬剤に対して高さを規制するようになっている薬剤フィーダにおいて、
前記垂下物として形状の異なる第1形の垂下物と第2形の垂下物とが設けられており、前記の第1形の垂下物が、下端部を横に押されると変形しうるものであり、前記の第2形の垂下物が、上端部を緩く支持されていて下端部を横に押されると変形せずに揺動しうるものである、ことを特徴とする薬剤フィーダ。
an outer annular rotating body that is rotatable about a vertical line; and an annular rotating body that is installed inside the annular rotating body so as to be rotatable about an inclined line that is inclined from the vertical line so as to open the hollow of the annular rotating body. a tilting rotary body for blocking, and a sorting member and a regulating member that align solid drugs carried from above onto the upper end peripheral edge of the annular rotary body by rotation of the tilting rotary body when the annular rotary body rotates. The regulating member is configured to regulate the width of the drug on the upper peripheral edge of the annular rotating body, and the sorting member hangs above the upper peripheral edge of the annular rotating body. In the drug feeder, the height of the drug above the upper end peripheral portion of the annular rotating body is regulated by comprising a hanging object,
A first type of hanging object and a second type of hanging object having different shapes are provided as the hanging object, and the first type of hanging object can be deformed when its lower end is pushed sideways. A drug feeder characterized in that the second type of hanging object is loosely supported at its upper end and can swing without being deformed when its lower end is pushed sideways.
前記の第1形の垂下物と前記の第2形の垂下物とが、前記環状回転体の周方向位置を異にしている、ことを特徴とする請求項1記載の薬剤フィーダ。 The drug feeder according to claim 1, wherein the first type of hanging object and the second type of hanging object are located at different positions in the circumferential direction of the annular rotating body. 前記の第2形の垂下物は、その全部または下端部の一部を含む部分が板状であり、この板状部分の下端面の長手方向の直線と前記環状回転体の前記上端周縁部の周方向の直線とが「ねじれの位置の直線」の関係を維持するようになっており、前記環状回転体によって移送されて前記の第2形の垂下物に当接した薬剤の移送方向が前記環状回転体の内周側へ向けられるようになっている、ことを特徴とする請求項1又は請求項2に記載された薬剤フィーダ。 The second type of hanging object has a plate shape in its entirety or a part including a part of its lower end, and a straight line in the longitudinal direction of the lower end surface of the plate-shaped part and the upper end peripheral edge of the annular rotating body. The straight line in the circumferential direction maintains a relationship of "straight line at the twisting position", and the direction of transport of the drug that is transported by the annular rotating body and comes into contact with the second type of hanging object is The drug feeder according to claim 1 or 2, wherein the drug feeder is oriented toward the inner peripheral side of the annular rotating body. 前記の第2形の垂下物が、並設された分離可能な複数部材からなるものである、ことを特徴とする請求項1乃至請求項3の何れかに記載された薬剤フィーダ。 The drug feeder according to any one of claims 1 to 3, wherein the second type of hanging object is composed of a plurality of separable members arranged in parallel. 前記の第2形の垂下物が、分離可能な状態で並設された複数枚の同一形状の板材からなるものである、ことを特徴とする請求項1乃至請求項3の何れかに記載された薬剤フィーダ。 The method according to any one of claims 1 to 3, characterized in that the second type of hanging object is made of a plurality of plates of the same shape arranged in parallel in a separable state. drug feeder.
JP2020205592A 2020-12-11 2020-12-11 drug feeder Active JP7424634B2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2020205592A JP7424634B2 (en) 2020-12-11 2020-12-11 drug feeder
CA3205054A CA3205054A1 (en) 2020-12-11 2021-12-09 Medicine feeder
PCT/JP2021/045336 WO2022124369A1 (en) 2020-12-11 2021-12-09 Drug feeder
EP21903468.3A EP4260839A1 (en) 2020-12-11 2021-12-09 Drug feeder
AU2021397601A AU2021397601A1 (en) 2020-12-11 2021-12-09 Medicine feeder
US18/256,506 US20240016703A1 (en) 2020-12-11 2021-12-09 Medicine feeder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020205592A JP7424634B2 (en) 2020-12-11 2020-12-11 drug feeder

Publications (2)

Publication Number Publication Date
JP2022092722A JP2022092722A (en) 2022-06-23
JP7424634B2 true JP7424634B2 (en) 2024-01-30

Family

ID=82069094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020205592A Active JP7424634B2 (en) 2020-12-11 2020-12-11 drug feeder

Country Status (1)

Country Link
JP (1) JP7424634B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008150170A (en) 2006-12-18 2008-07-03 Yuki Engineering Co Ltd Aligning/feeding device
JP6736075B1 (en) 2020-01-29 2020-08-05 株式会社トーショー Drug feeder
JP2021115368A (en) 2020-01-29 2021-08-10 株式会社トーショー Medicine feeder

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008150170A (en) 2006-12-18 2008-07-03 Yuki Engineering Co Ltd Aligning/feeding device
JP6736075B1 (en) 2020-01-29 2020-08-05 株式会社トーショー Drug feeder
JP2021115368A (en) 2020-01-29 2021-08-10 株式会社トーショー Medicine feeder

Also Published As

Publication number Publication date
JP2022092722A (en) 2022-06-23

Similar Documents

Publication Publication Date Title
JP6736075B1 (en) Drug feeder
JP6736064B2 (en) Drug feeder
JP6135742B2 (en) Drug discharge device
JP6736074B1 (en) Drug feeder
JP7424634B2 (en) drug feeder
JP7337382B2 (en) drug feeder
JP7281145B2 (en) drug feeder
JP7337383B2 (en) drug feeder
WO2021153674A1 (en) Drug feeder
JP7325756B2 (en) drug feeder
JP4562665B2 (en) Chemical dispensing device
JP2022100541A (en) Medicine feeder
JP7337388B2 (en) drug feeder
WO2022186348A1 (en) Drug feeder
WO2023181610A1 (en) Drug feeder and tablet packing machine
JP2022106557A (en) Medicine feeder and dispensing system
WO2022124369A1 (en) Drug feeder
US10329098B2 (en) Automated vial hopper and feeder assembly
JP2009023844A (en) Approximately cylindrical article put-out device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230703

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240109

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240111

R150 Certificate of patent or registration of utility model

Ref document number: 7424634

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150